<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:b23760e0-ceea-4c87-a713-0848085982cc,g:0499c82a-b630-4b22-a9b0-ab69f2ad42df-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Cover" xlink:type="simple" xlink:href="jazz-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b7bb0021-edf0-440b-8baa-853c9e048e26" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentType_b7bb0021-edf0-440b-8baa-853c9e048e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_df0f0ab8-42e7-48d6-a151-85cf5a05df7b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentQuarterlyReport_df0f0ab8-42e7-48d6-a151-85cf5a05df7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_32bff172-0974-4643-bff9-51c1641709d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentPeriodEndDate_32bff172-0974-4643-bff9-51c1641709d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8a71fd35-9f66-449d-aafd-38be0fd75a2e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentTransitionReport_8a71fd35-9f66-449d-aafd-38be0fd75a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_fdb9c766-d334-4252-b76c-7c47e2a32cfa" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityFileNumber_fdb9c766-d334-4252-b76c-7c47e2a32cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6899cb95-67d6-45c3-b0f7-7d2803509c14" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityRegistrantName_6899cb95-67d6-45c3-b0f7-7d2803509c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f233bb2d-39c1-4327-b5da-2ab3a6764802" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f233bb2d-39c1-4327-b5da-2ab3a6764802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1adcda88-6556-437c-8481-8390fbae471e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityTaxIdentificationNumber_1adcda88-6556-437c-8481-8390fbae471e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a56f778f-e510-4d60-bbcc-6bb4886912ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityAddressAddressLine1_a56f778f-e510-4d60-bbcc-6bb4886912ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_ec685c08-6edb-4fd1-9ece-a98eb49b7bf9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityAddressAddressLine2_ec685c08-6edb-4fd1-9ece-a98eb49b7bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_088d826e-311a-4e72-9772-c4aed8be1840" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityAddressCityOrTown_088d826e-311a-4e72-9772-c4aed8be1840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_4731b7ce-3ba6-4382-b16d-c108723bbca3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityAddressCountry_4731b7ce-3ba6-4382-b16d-c108723bbca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_7b286a23-638a-4f28-9b64-741195d80e6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityAddressPostalZipCode_7b286a23-638a-4f28-9b64-741195d80e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_9490d384-af0d-4528-a813-f9c1153df88f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_CountryRegion_9490d384-af0d-4528-a813-f9c1153df88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa16e537-f263-4f5f-a7c2-e2a6b6bd30c5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_CityAreaCode_fa16e537-f263-4f5f-a7c2-e2a6b6bd30c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9323fcae-ba0b-419c-9b59-9a0e3be0421f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_LocalPhoneNumber_9323fcae-ba0b-419c-9b59-9a0e3be0421f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_7d20ba22-f9f3-4977-b3d4-6d77d67682c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_Security12bTitle_7d20ba22-f9f3-4977-b3d4-6d77d67682c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d753e51e-46a9-4723-a951-3099264f2c01" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_TradingSymbol_d753e51e-46a9-4723-a951-3099264f2c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e9aa0c93-d540-4b33-abdf-fdada000218f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_SecurityExchangeName_e9aa0c93-d540-4b33-abdf-fdada000218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_932e062b-4cbb-49f1-8ed2-70ad1517bebc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityCurrentReportingStatus_932e062b-4cbb-49f1-8ed2-70ad1517bebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_caab1fc0-a502-4b30-8e9d-d48fade73773" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityInteractiveDataCurrent_caab1fc0-a502-4b30-8e9d-d48fade73773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_0dae2564-c6c4-40dc-a1e8-c18899e12824" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityFilerCategory_0dae2564-c6c4-40dc-a1e8-c18899e12824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_46f87700-f85d-4be4-b37e-a738fc0b35b5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntitySmallBusiness_46f87700-f85d-4be4-b37e-a738fc0b35b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1d0fecd9-ed2f-4980-b63c-fe8ff1fc5dd4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityEmergingGrowthCompany_1d0fecd9-ed2f-4980-b63c-fe8ff1fc5dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a50a7e82-12b3-4cad-a7a7-aa9673c1fc83" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityShellCompany_a50a7e82-12b3-4cad-a7a7-aa9673c1fc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2f98747d-7684-42c2-abf2-20be5f2b4c51" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2f98747d-7684-42c2-abf2-20be5f2b4c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dabd959c-b1ca-4d12-9374-e05a838bf9cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_AmendmentFlag_dabd959c-b1ca-4d12-9374-e05a838bf9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_95c22645-58f2-4bcb-83cb-bfa829ccc0d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentFiscalYearFocus_95c22645-58f2-4bcb-83cb-bfa829ccc0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7a60ffb3-cde8-4030-b9bd-4d04372402de" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7a60ffb3-cde8-4030-b9bd-4d04372402de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fdb1f00a-954a-4fb6-9053-5dc0bc280f7f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_EntityCentralIndexKey_fdb1f00a-954a-4fb6-9053-5dc0bc280f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bdd0b1af-0935-4c5f-bd23-40f062773107" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e60a5e9b-2cd4-4c6c-9f83-c25cd84e3a92" xlink:to="loc_dei_CurrentFiscalYearEndDate_bdd0b1af-0935-4c5f-bd23-40f062773107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensenedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensenedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensenedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c9ee7edd-b1c3-4fb9-94c7-4e70f1e4c132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9ee7edd-b1c3-4fb9-94c7-4e70f1e4c132" xlink:to="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd47119a-1e45-4d1e-80e3-74f395f7c3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd47119a-1e45-4d1e-80e3-74f395f7c3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_36737ec2-a27c-4b1b-a43f-fd7ace66658a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_36737ec2-a27c-4b1b-a43f-fd7ace66658a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5af541d0-30e7-46d2-8bd4-14bc0110b660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_InventoryNet_5af541d0-30e7-46d2-8bd4-14bc0110b660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_adfea918-a846-4040-9194-b3a5798d6d71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_adfea918-a846-4040-9194-b3a5798d6d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a07529d8-9a3c-46df-9cd6-19942cfdbd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_OtherAssetsCurrent_a07529d8-9a3c-46df-9cd6-19942cfdbd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_692c5e70-663c-42bd-af4e-0002385e191b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_692c5e70-663c-42bd-af4e-0002385e191b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0f3cca87-d65a-4698-a881-7ea85ac1c028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f50cb572-2b33-47b8-95e9-e2b07ef89b30" xlink:to="loc_us-gaap_AssetsCurrent_0f3cca87-d65a-4698-a881-7ea85ac1c028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25b953aa-79bf-4b88-9fa4-b5976c3c01ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25b953aa-79bf-4b88-9fa4-b5976c3c01ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_de169890-ca1f-42f3-9999-1a0753caf57f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_de169890-ca1f-42f3-9999-1a0753caf57f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b6a22c9b-1cf8-4fe3-9865-3d5644d6bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b6a22c9b-1cf8-4fe3-9865-3d5644d6bdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_68a6f913-9727-4472-88d4-cf08bdeff930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_Goodwill_68a6f913-9727-4472-88d4-cf08bdeff930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_41b7cf97-d4dd-4f0f-ab34-a1800d46fd66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_41b7cf97-d4dd-4f0f-ab34-a1800d46fd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_9773c3b7-92f9-4709-a642-09d568053cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_9773c3b7-92f9-4709-a642-09d568053cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_98ab283b-57da-4d64-a1ed-3d7ff561b043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_98ab283b-57da-4d64-a1ed-3d7ff561b043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6cec562f-ad4a-42c0-b60a-596dbda5f93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4f06a01d-4431-4dd4-af09-78b47bc47619" xlink:to="loc_us-gaap_Assets_6cec562f-ad4a-42c0-b60a-596dbda5f93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c9ee7edd-b1c3-4fb9-94c7-4e70f1e4c132" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b5e3b63e-7232-4fc3-9bb5-7183a34920d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_AccountsPayableCurrent_b5e3b63e-7232-4fc3-9bb5-7183a34920d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8b58aab3-7fd1-4153-aa6a-1a7937b3dceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8b58aab3-7fd1-4153-aa6a-1a7937b3dceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_11653a0a-64e4-4952-ad64-4a97665edc3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_LongTermDebtCurrent_11653a0a-64e4-4952-ad64-4a97665edc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_ca9caba0-e84e-461a-9733-252cc5fd1344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_TaxesPayableCurrent_ca9caba0-e84e-461a-9733-252cc5fd1344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_325199da-bbc3-453e-9985-5ca12f4f1124" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_325199da-bbc3-453e-9985-5ca12f4f1124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_13d8460e-fc31-4b63-982a-454545f703ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_5d3d9efb-48b0-4033-9bbe-9f79a53b3ec9" xlink:to="loc_us-gaap_LiabilitiesCurrent_13d8460e-fc31-4b63-982a-454545f703ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_573e88be-7d67-4e74-969c-b35368c9234d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_573e88be-7d67-4e74-969c-b35368c9234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_ca9e3528-6959-4601-ad4a-801bb17ed6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_ca9e3528-6959-4601-ad4a-801bb17ed6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05675134-39c8-47e6-9bdf-db087dfc58ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_05675134-39c8-47e6-9bdf-db087dfc58ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bd959bdc-bf69-4cfb-b16c-4b41b701747e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bd959bdc-bf69-4cfb-b16c-4b41b701747e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1e8a2124-812e-4e9b-a846-4e317158aae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1e8a2124-812e-4e9b-a846-4e317158aae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ee7c87ff-7955-409e-910b-7346074b88cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ee7c87ff-7955-409e-910b-7346074b88cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b73a2877-5fd1-4289-96cc-9a9050427e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_us-gaap_CommonStockValue_b73a2877-5fd1-4289-96cc-9a9050427e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NonvotingEuroDeferredShares_64247861-e29f-4784-8ebb-6c42af21e972" xlink:href="jazz-20220331.xsd#jazz_NonvotingEuroDeferredShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_jazz_NonvotingEuroDeferredShares_64247861-e29f-4784-8ebb-6c42af21e972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserve_5e8d5ea4-38bb-428b-a249-ca2e9a208af5" xlink:href="jazz-20220331.xsd#jazz_CapitalRedemptionReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_jazz_CapitalRedemptionReserve_5e8d5ea4-38bb-428b-a249-ca2e9a208af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_afc60dcd-a3d3-49fe-9572-b0fd5456cc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_afc60dcd-a3d3-49fe-9572-b0fd5456cc2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1ed89d9b-4c57-4653-8702-78fd9f7f2622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1ed89d9b-4c57-4653-8702-78fd9f7f2622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6511c2ed-e1a2-443d-a76b-c1569740c120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6511c2ed-e1a2-443d-a76b-c1569740c120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a76db40b-343f-4459-ad81-2e2ead9ddf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5d7d4f1a-0931-45ac-8d4b-5cab8d881b66" xlink:to="loc_us-gaap_StockholdersEquity_a76db40b-343f-4459-ad81-2e2ead9ddf3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d947051f-a0f4-4cbd-8d8d-a1db20dabe76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_853500e7-1003-435d-9583-b80283b1e7f4" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_d947051f-a0f4-4cbd-8d8d-a1db20dabe76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensedConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_51ddac84-ae2f-4e0d-8e08-e3d0b649c071" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ed517d36-a54a-4204-b97c-f0b2daeb3a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_51ddac84-ae2f-4e0d-8e08-e3d0b649c071" xlink:to="loc_us-gaap_StatementTable_ed517d36-a54a-4204-b97c-f0b2daeb3a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a12ada90-0c9d-4d11-84f6-426146efcc77" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ed517d36-a54a-4204-b97c-f0b2daeb3a9c" xlink:to="loc_srt_ProductOrServiceAxis_a12ada90-0c9d-4d11-84f6-426146efcc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4cf3e30a-fb75-44be-bbae-fd686727e281" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a12ada90-0c9d-4d11-84f6-426146efcc77" xlink:to="loc_srt_ProductsAndServicesDomain_4cf3e30a-fb75-44be-bbae-fd686727e281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_e569e4b6-8e6a-419f-a65e-747ba0abeb09" xlink:href="jazz-20220331.xsd#jazz_ProductAndServicesProductSalesNetOfDeductionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4cf3e30a-fb75-44be-bbae-fd686727e281" xlink:to="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_e569e4b6-8e6a-419f-a65e-747ba0abeb09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_33b5bf59-d652-477e-91d4-39c7bbd6af9b" xlink:href="jazz-20220331.xsd#jazz_ProductAndServicesRoyaltiesAndContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4cf3e30a-fb75-44be-bbae-fd686727e281" xlink:to="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_33b5bf59-d652-477e-91d4-39c7bbd6af9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ed517d36-a54a-4204-b97c-f0b2daeb3a9c" xlink:to="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_97d437cf-92a0-4c30-895e-831267f58240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_RevenuesAbstract_97d437cf-92a0-4c30-895e-831267f58240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ef42379c-152e-42c6-af8a-1a05e7eca51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_97d437cf-92a0-4c30-895e-831267f58240" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ef42379c-152e-42c6-af8a-1a05e7eca51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_da8ff3a4-09d0-4dc9-9710-92a5131b1c6f" xlink:href="jazz-20220331.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_da8ff3a4-09d0-4dc9-9710-92a5131b1c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_420f4987-1d60-4498-8a5b-af9e634c0e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_420f4987-1d60-4498-8a5b-af9e634c0e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d3a5a087-e4a5-4b09-b0d0-57a5cd7c7602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_d3a5a087-e4a5-4b09-b0d0-57a5cd7c7602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b81b9e2d-338e-40e2-971a-894f491ddcff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b81b9e2d-338e-40e2-971a-894f491ddcff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_1dcd902e-a451-47e4-b111-2799e752269b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1824fb8d-68de-44f0-9e36-55688b8cd803" xlink:to="loc_us-gaap_CostsAndExpenses_1dcd902e-a451-47e4-b111-2799e752269b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1b6fa1d7-60f3-49ba-ae57-13126a4d8203" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_OperatingIncomeLoss_1b6fa1d7-60f3-49ba-ae57-13126a4d8203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_faab527f-57c9-4c55-aea4-cb63734cdaa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_faab527f-57c9-4c55-aea4-cb63734cdaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_993c3793-f96f-4561-b5ef-3f9ab9f26cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_993c3793-f96f-4561-b5ef-3f9ab9f26cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_640f398f-8c02-444f-bd73-a12f9b6169e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_640f398f-8c02-444f-bd73-a12f9b6169e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_06f124a8-c49c-4a47-9328-7e7e128cc9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_06f124a8-c49c-4a47-9328-7e7e128cc9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cd899f60-caa7-44cb-9436-af87eab3bee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cd899f60-caa7-44cb-9436-af87eab3bee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e48fabf9-ae79-4ae6-b5a6-3bda731107e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_NetIncomeLoss_e48fabf9-ae79-4ae6-b5a6-3bda731107e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26f24eff-1430-4201-b1c0-5eab4a576fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26f24eff-1430-4201-b1c0-5eab4a576fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4b59bd3d-2dab-455f-84b9-d150fa76efef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26f24eff-1430-4201-b1c0-5eab4a576fbb" xlink:to="loc_us-gaap_EarningsPerShareBasic_4b59bd3d-2dab-455f-84b9-d150fa76efef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6b141397-aaa1-4057-8828-0c4fa699944c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_26f24eff-1430-4201-b1c0-5eab4a576fbb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6b141397-aaa1-4057-8828-0c4fa699944c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d32b8480-f123-4803-ab1f-bfb0d573966a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d32b8480-f123-4803-ab1f-bfb0d573966a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e441ad2b-7453-43d9-b762-6a71bb03d310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_236a229c-c6d8-44e6-b430-9c976dffcdd6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e441ad2b-7453-43d9-b762-6a71bb03d310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_91d82dc7-f62a-420d-bb9c-302aa20043c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bc1d02fc-81d9-45d1-a61d-47a717bbc8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_91d82dc7-f62a-420d-bb9c-302aa20043c8" xlink:to="loc_us-gaap_NetIncomeLoss_bc1d02fc-81d9-45d1-a61d-47a717bbc8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_91d82dc7-f62a-420d-bb9c-302aa20043c8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f013e1a3-128f-4107-9bab-55c6a45f133b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_f013e1a3-128f-4107-9bab-55c6a45f133b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax_f41bc9e8-4ad7-4b51-8f7d-26364597fa2c" xlink:href="jazz-20220331.xsd#jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:to="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationAndTax_f41bc9e8-4ad7-4b51-8f7d-26364597fa2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d993c114-d599-48c7-a9b4-2fe026f7e390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_d993c114-d599-48c7-a9b4-2fe026f7e390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax_b92b785f-0d70-420b-a75a-cb5cf80cb05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax_b92b785f-0d70-420b-a75a-cb5cf80cb05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9f649cf1-35c9-46ad-bf1d-705445d06245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_2d79e5c1-56d4-4b7f-be1a-2684ea782925" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9f649cf1-35c9-46ad-bf1d-705445d06245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e338df25-2926-47ad-b65d-06d0c21a70ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_91d82dc7-f62a-420d-bb9c-302aa20043c8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e338df25-2926-47ad-b65d-06d0c21a70ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossParenthetical" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ee363e9-abca-49a2-be2c-66cdeb5a4042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax_30d255f6-ebac-4894-b63b-ddfb8b54ec5a" xlink:href="jazz-20220331.xsd#jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ee363e9-abca-49a2-be2c-66cdeb5a4042" xlink:to="loc_jazz_OtherComprehensiveIncomeLossFairValueHedgeGainLossAfterReclassificationTax_30d255f6-ebac-4894-b63b-ddfb8b54ec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_54c2736d-7bc2-40ed-9024-b1cccfb4848c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ee363e9-abca-49a2-be2c-66cdeb5a4042" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_54c2736d-7bc2-40ed-9024-b1cccfb4848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax_674bb4b5-8da2-4dfa-91a6-aa39902b5f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9ee363e9-abca-49a2-be2c-66cdeb5a4042" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax_674bb4b5-8da2-4dfa-91a6-aa39902b5f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_834b6f92-ad5a-43b4-9444-af9867aa2dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_60ebc8a7-9f71-44a0-9c3f-5576dfa5998d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_834b6f92-ad5a-43b4-9444-af9867aa2dff" xlink:to="loc_us-gaap_StatementTable_60ebc8a7-9f71-44a0-9c3f-5576dfa5998d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_060df09a-b2e6-4523-b449-021cf8eb28d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_60ebc8a7-9f71-44a0-9c3f-5576dfa5998d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_060df09a-b2e6-4523-b449-021cf8eb28d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_060df09a-b2e6-4523-b449-021cf8eb28d1" xlink:to="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_94cabb59-05a9-48c4-9011-811219e55873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_us-gaap_CommonStockMember_94cabb59-05a9-48c4-9011-811219e55873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EuroDeferredSharesMember_9c446610-f2a5-4a17-a12b-c10a48ec5459" xlink:href="jazz-20220331.xsd#jazz_EuroDeferredSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_jazz_EuroDeferredSharesMember_9c446610-f2a5-4a17-a12b-c10a48ec5459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserveMember_f73b4abb-c243-4255-b279-f5daa0742cb5" xlink:href="jazz-20220331.xsd#jazz_CapitalRedemptionReserveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_jazz_CapitalRedemptionReserveMember_f73b4abb-c243-4255-b279-f5daa0742cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_014c3d0a-d7fc-4c08-97d7-d78dd9630965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_014c3d0a-d7fc-4c08-97d7-d78dd9630965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_731e3968-267b-4290-ae0d-0abe680e7ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_731e3968-267b-4290-ae0d-0abe680e7ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_80fe4742-eed6-47de-9e66-42bb8ddb974d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_ffe5169c-5509-422e-84e8-00b93b67424b" xlink:to="loc_us-gaap_RetainedEarningsMember_80fe4742-eed6-47de-9e66-42bb8ddb974d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdc17bc2-e137-48ba-bc13-96896f062855" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_60ebc8a7-9f71-44a0-9c3f-5576dfa5998d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdc17bc2-e137-48ba-bc13-96896f062855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8c3b4634-67d1-451b-8b78-c35c3ed9faaa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_fdc17bc2-e137-48ba-bc13-96896f062855" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8c3b4634-67d1-451b-8b78-c35c3ed9faaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7eb8b680-e0ff-4a57-9940-d01fb14dc7ed" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_8c3b4634-67d1-451b-8b78-c35c3ed9faaa" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7eb8b680-e0ff-4a57-9940-d01fb14dc7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9017afb0-1343-4a27-9a47-e2aadb667adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_60ebc8a7-9f71-44a0-9c3f-5576dfa5998d" xlink:to="loc_us-gaap_StatementLineItems_9017afb0-1343-4a27-9a47-e2aadb667adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9017afb0-1343-4a27-9a47-e2aadb667adf" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_16b7426d-b7d3-486b-a1ca-98ccacbd6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_SharesOutstanding_16b7426d-b7d3-486b-a1ca-98ccacbd6e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_af02df2d-6347-4fd9-9496-e06ec8746e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockholdersEquity_af02df2d-6347-4fd9-9496-e06ec8746e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_86432b25-3f79-4508-a113-2fc6b58d4fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockholdersEquity_86432b25-3f79-4508-a113-2fc6b58d4fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b24863-8787-42d3-9f43-0bf2e8e82126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_61b24863-8787-42d3-9f43-0bf2e8e82126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c1de8d04-d792-410a-9d33-74ab4a7c8086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_c1de8d04-d792-410a-9d33-74ab4a7c8086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_247b1fdf-fd65-47d7-801a-0452af682292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_247b1fdf-fd65-47d7-801a-0452af682292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7d1577bd-54fb-46c4-a7ed-2379bd611b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7d1577bd-54fb-46c4-a7ed-2379bd611b6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e19255e9-5652-4909-8ce5-a8dcfb2be3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_e19255e9-5652-4909-8ce5-a8dcfb2be3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_38bce1bc-971c-4d55-810d-f8c7286a35e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_38bce1bc-971c-4d55-810d-f8c7286a35e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b8c4a5bb-45e7-4e7c-ac79-27155f4e3639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_NetIncomeLoss_b8c4a5bb-45e7-4e7c-ac79-27155f4e3639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e466a147-72bf-42b8-8414-6231795efbac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_SharesOutstanding_e466a147-72bf-42b8-8414-6231795efbac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d989a34e-4d7d-4f92-b059-9727e3aea4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_503c063a-d850-4f9d-9cd6-830fa61a1b44" xlink:to="loc_us-gaap_StockholdersEquity_d989a34e-4d7d-4f92-b059-9727e3aea4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e867228c-4f27-493b-aa8c-80cb8c6f2088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9017afb0-1343-4a27-9a47-e2aadb667adf" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_e867228c-4f27-493b-aa8c-80cb8c6f2088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jazz-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6718bd93-5c04-4236-8276-fe333fa270f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6718bd93-5c04-4236-8276-fe333fa270f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_edcfd16d-5cb1-4117-8ea1-18f7f33e95b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6718bd93-5c04-4236-8276-fe333fa270f3" xlink:to="loc_us-gaap_NetIncomeLoss_edcfd16d-5cb1-4117-8ea1-18f7f33e95b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6718bd93-5c04-4236-8276-fe333fa270f3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_15dc7d58-0088-4be6-a34a-d83c091e5b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_15dc7d58-0088-4be6-a34a-d83c091e5b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InventoryStepUpValueAdjustment_71ff8a7b-7546-46d9-b498-60862dc787ac" xlink:href="jazz-20220331.xsd#jazz_InventoryStepUpValueAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_jazz_InventoryStepUpValueAdjustment_71ff8a7b-7546-46d9-b498-60862dc787ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_30c8ca07-6b3a-457f-9a13-a8277d346825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_ShareBasedCompensation_30c8ca07-6b3a-457f-9a13-a8277d346825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_24ce0afa-8cef-4356-8e56-0376d799909c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_24ce0afa-8cef-4356-8e56-0376d799909c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NoncashInterestExpense_180f2218-fe19-46e1-b88d-ab445492d8ac" xlink:href="jazz-20220331.xsd#jazz_NoncashInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_jazz_NoncashInterestExpense_180f2218-fe19-46e1-b88d-ab445492d8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_aeed376c-d429-41e7-85ca-f34495269478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_Depreciation_aeed376c-d429-41e7-85ca-f34495269478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_d8bacee1-821a-44ea-88d3-d998abba87f1" xlink:href="jazz-20220331.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_d8bacee1-821a-44ea-88d3-d998abba87f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_19bc48ca-8c1a-4360-83ce-5e2983a1bf96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_19bc48ca-8c1a-4360-83ce-5e2983a1bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_004e9567-f520-4645-b616-aaba01c80b5e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f486a112-211a-4d16-ad5d-a4e1ca1c9e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f486a112-211a-4d16-ad5d-a4e1ca1c9e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f01ddd3f-a901-46f3-a0c9-de28b874467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f01ddd3f-a901-46f3-a0c9-de28b874467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e34df24f-afdb-4bed-a11c-0c5bc34f8252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e34df24f-afdb-4bed-a11c-0c5bc34f8252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_af202c22-6b1c-4477-92dc-e8632e5d272f" xlink:href="jazz-20220331.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_af202c22-6b1c-4477-92dc-e8632e5d272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a066ab6e-0893-41f5-9eb0-e807725405f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_a066ab6e-0893-41f5-9eb0-e807725405f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c240f6ac-13e5-4814-bb79-05e03819d8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_c240f6ac-13e5-4814-bb79-05e03819d8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5231f4fc-39af-476d-9646-56802c5345ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5231f4fc-39af-476d-9646-56802c5345ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_21f25cb4-9239-41b7-885e-dd4ee81cb141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_21f25cb4-9239-41b7-885e-dd4ee81cb141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1802f4d9-5cbf-43be-be46-3f644acb163c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1802f4d9-5cbf-43be-be46-3f644acb163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_cf9dd484-0ad3-4a38-bfb6-ad7701c7a4c8" xlink:href="jazz-20220331.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_cf9dd484-0ad3-4a38-bfb6-ad7701c7a4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fa6b9cdd-87d0-4cdb-9ded-c1cc774b7dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_036aafa5-2800-4b30-83ba-8b4cc7b1bcd7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_fa6b9cdd-87d0-4cdb-9ded-c1cc774b7dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36953cf9-c8ad-4148-8e44-2fa0f5e31676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6718bd93-5c04-4236-8276-fe333fa270f3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_36953cf9-c8ad-4148-8e44-2fa0f5e31676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_823b8717-3fd9-41e8-b420-1cadf36efe48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_823b8717-3fd9-41e8-b420-1cadf36efe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c4a1c3bc-cdcb-4577-ad1c-ccf009782b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c4a1c3bc-cdcb-4577-ad1c-ccf009782b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b946bda3-a81e-4731-91f6-0fe2b17de164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b946bda3-a81e-4731-91f6-0fe2b17de164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_6613c389-567f-4b25-8218-660038ef9c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_6613c389-567f-4b25-8218-660038ef9c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_33b42feb-5272-416f-b21d-a1335b4f0fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_db2e8067-ccdc-4555-9c6f-63400188555e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_33b42feb-5272-416f-b21d-a1335b4f0fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e1bd80ec-46c3-4375-ad06-599baf4550ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e1bd80ec-46c3-4375-ad06-599baf4550ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_48b66713-a55a-4c9b-9902-f71902e4a1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_48b66713-a55a-4c9b-9902-f71902e4a1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_c6a18c97-eb2a-451e-a7f3-82eff2e4b6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_c6a18c97-eb2a-451e-a7f3-82eff2e4b6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa215d91-60ac-4e66-bb49-71cf6219de70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b6a59fd-4bdb-48d6-baf3-b34b7ea5a84a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa215d91-60ac-4e66-bb49-71cf6219de70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6c5bb204-578e-4414-a65b-44c8f0c5a4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6c5bb204-578e-4414-a65b-44c8f0c5a4e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc455931-5102-4eb3-ba92-8625c34db50e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc455931-5102-4eb3-ba92-8625c34db50e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77078ee-7fa8-4376-a3c9-4e6c587228cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77078ee-7fa8-4376-a3c9-4e6c587228cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2632b0d-b4f3-4f3e-8247-543a16ab896a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_86e35fe3-6012-4a30-ac5b-28537035ffeb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b2632b0d-b4f3-4f3e-8247-543a16ab896a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_149a567d-9418-4afc-ba4f-66d967d9d25e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3f02c95c-4dde-4cb8-a2e8-b07539bae9cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_149a567d-9418-4afc-ba4f-66d967d9d25e" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_3f02c95c-4dde-4cb8-a2e8-b07539bae9cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_0939db4b-6ba2-484b-80e7-7b509ae3a478" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_0939db4b-6ba2-484b-80e7-7b509ae3a478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e4aefa9c-d436-4818-9b87-826908d935cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:to="loc_us-gaap_UseOfEstimates_e4aefa9c-d436-4818-9b87-826908d935cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5ab74f48-f4c3-4544-845b-75536c9049e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5ab74f48-f4c3-4544-845b-75536c9049e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SignificantRisksAndUncertaintiesPolicyTextBlock_8f692472-5fb4-487f-93ec-0c9a56adecdb" xlink:href="jazz-20220331.xsd#jazz_SignificantRisksAndUncertaintiesPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:to="loc_jazz_SignificantRisksAndUncertaintiesPolicyTextBlock_8f692472-5fb4-487f-93ec-0c9a56adecdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_67952d27-957a-413c-aa03-80f2e3f193d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c26ea6db-6e3a-4bd0-84a3-03f11f2b9bed" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_67952d27-957a-413c-aa03-80f2e3f193d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_106cb7a9-1124-453a-a51b-afb78565a2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_4b5b3100-62c6-4cae-8ddb-82b826821b3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_106cb7a9-1124-453a-a51b-afb78565a2bc" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_4b5b3100-62c6-4cae-8ddb-82b826821b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b7b9084b-d381-43bb-bf17-bca9a7e54afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c5372d1e-ac0c-4f2a-82c3-818a225d01c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b7b9084b-d381-43bb-bf17-bca9a7e54afe" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c5372d1e-ac0c-4f2a-82c3-818a225d01c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a702e591-76e7-4675-a021-b6e29910c46a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5372d1e-ac0c-4f2a-82c3-818a225d01c5" xlink:to="loc_srt_ProductOrServiceAxis_a702e591-76e7-4675-a021-b6e29910c46a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_813efef3-c6a4-44d2-9222-722715b90803" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a702e591-76e7-4675-a021-b6e29910c46a" xlink:to="loc_srt_ProductsAndServicesDomain_813efef3-c6a4-44d2-9222-722715b90803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SativexMember_df67c081-54d1-4128-852d-8ccdf015056a" xlink:href="jazz-20220331.xsd#jazz_SativexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_813efef3-c6a4-44d2-9222-722715b90803" xlink:to="loc_jazz_SativexMember_df67c081-54d1-4128-852d-8ccdf015056a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f4aa22bc-49b1-4788-a65e-9526e8f698f8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5372d1e-ac0c-4f2a-82c3-818a225d01c5" xlink:to="loc_srt_StatementGeographicalAxis_f4aa22bc-49b1-4788-a65e-9526e8f698f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_121fa9a1-b67b-4bc2-b240-59e180e2ca61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f4aa22bc-49b1-4788-a65e-9526e8f698f8" xlink:to="loc_srt_SegmentGeographicalDomain_121fa9a1-b67b-4bc2-b240-59e180e2ca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OutsideUnitedStatesMember_1334bedc-3de8-481d-8fcb-e3a36763e144" xlink:href="jazz-20220331.xsd#jazz_OutsideUnitedStatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_121fa9a1-b67b-4bc2-b240-59e180e2ca61" xlink:to="loc_jazz_OutsideUnitedStatesMember_1334bedc-3de8-481d-8fcb-e3a36763e144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_dd9e0fb4-76e6-4292-bc26-6c4c852cf400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c5372d1e-ac0c-4f2a-82c3-818a225d01c5" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_dd9e0fb4-76e6-4292-bc26-6c4c852cf400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NumberOfMarketsProductApprovedAndMarketed_234ce3b3-887c-4a2a-a705-68ea5d6df894" xlink:href="jazz-20220331.xsd#jazz_NumberOfMarketsProductApprovedAndMarketed"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dd9e0fb4-76e6-4292-bc26-6c4c852cf400" xlink:to="loc_jazz_NumberOfMarketsProductApprovedAndMarketed_234ce3b3-887c-4a2a-a705-68ea5d6df894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5dd6d6d7-cb7e-42d2-883c-462bc29b1d40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_dd9e0fb4-76e6-4292-bc26-6c4c852cf400" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5dd6d6d7-cb7e-42d2-883c-462bc29b1d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesAdoptionofNewAccountingStandardsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesAdoptionofNewAccountingStandardsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesAdoptionofNewAccountingStandardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bc9fae24-f883-47a8-afd8-e3bd383be425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bc9fae24-f883-47a8-afd8-e3bd383be425" xlink:to="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_965f097a-ef79-43dc-ba17-f83da7f0d5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:to="loc_us-gaap_DebtInstrumentAxis_965f097a-ef79-43dc-ba17-f83da7f0d5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d8a52e39-e916-40f6-a0a2-a032890c1900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_965f097a-ef79-43dc-ba17-f83da7f0d5d9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d8a52e39-e916-40f6-a0a2-a032890c1900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_ff2a7d7e-2ab0-4bfa-94dc-a944a7c18b8c" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8a52e39-e916-40f6-a0a2-a032890c1900" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_ff2a7d7e-2ab0-4bfa-94dc-a944a7c18b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_59f30e2d-edf2-4bf9-83bd-923222f5e0f2" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d8a52e39-e916-40f6-a0a2-a032890c1900" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_59f30e2d-edf2-4bf9-83bd-923222f5e0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_07fab06e-07f5-4756-a39e-9842fcf93428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_07fab06e-07f5-4756-a39e-9842fcf93428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_67301729-aeb4-44e7-be73-8280a2b32256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_07fab06e-07f5-4756-a39e-9842fcf93428" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_67301729-aeb4-44e7-be73-8280a2b32256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_bcce685a-27df-4e41-b7e8-9e63112c0a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_67301729-aeb4-44e7-be73-8280a2b32256" xlink:to="loc_us-gaap_ConvertibleDebtMember_bcce685a-27df-4e41-b7e8-9e63112c0a3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7c735d4c-a497-4c7c-ad97-38ba47bd73d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7c735d4c-a497-4c7c-ad97-38ba47bd73d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_95b9d7da-e3bb-467a-b921-aa3adb94985a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_7c735d4c-a497-4c7c-ad97-38ba47bd73d2" xlink:to="loc_us-gaap_TypeOfAdoptionMember_95b9d7da-e3bb-467a-b921-aa3adb94985a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_582e28a8-c33b-49fd-bc87-bd09a9a4e733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_95b9d7da-e3bb-467a-b921-aa3adb94985a" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_582e28a8-c33b-49fd-bc87-bd09a9a4e733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2af1a40c-b232-4540-beed-1ce208c8a0e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2af1a40c-b232-4540-beed-1ce208c8a0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1f8ce678-6202-4566-86d6-276cbe04f333" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_2af1a40c-b232-4540-beed-1ce208c8a0e9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1f8ce678-6202-4566-86d6-276cbe04f333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_00859f9d-ad39-4127-a408-9020856d3c8d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1f8ce678-6202-4566-86d6-276cbe04f333" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_00859f9d-ad39-4127-a408-9020856d3c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_036e8578-ee48-4b28-9361-d6e2ac02e92f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_1f8ce678-6202-4566-86d6-276cbe04f333" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_036e8578-ee48-4b28-9361-d6e2ac02e92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_67cf59d8-0bcd-4361-b629-bdece52a492c" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7d205f08-86d5-44e2-8806-ecd91e04b196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7d205f08-86d5-44e2-8806-ecd91e04b196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7fe2ae7b-6940-4a63-a347-c85b35d157d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7fe2ae7b-6940-4a63-a347-c85b35d157d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8762fc51-48dd-4f5f-813e-3ad6c7ae37aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8762fc51-48dd-4f5f-813e-3ad6c7ae37aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85fda4b8-cd18-46d4-a9cf-0ee157160c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_85fda4b8-cd18-46d4-a9cf-0ee157160c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fa90e214-68cb-4ff5-9427-4a29f0a840da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fa90e214-68cb-4ff5-9427-4a29f0a840da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b0ac7a9c-55e5-4f6c-948d-fc05b96f436c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_InterestExpense_b0ac7a9c-55e5-4f6c-948d-fc05b96f436c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2b256ad4-643b-43f8-bcdf-eb78b7ad68fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_EarningsPerShareBasic_2b256ad4-643b-43f8-bcdf-eb78b7ad68fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8d593542-0c51-4a78-9544-94a3aa868942" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_406f0ffb-8cd1-4bd9-b5c7-7ced69809e01" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8d593542-0c51-4a78-9544-94a3aa868942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f244f3f5-02f5-42d1-892f-2531ebca3af5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f244f3f5-02f5-42d1-892f-2531ebca3af5" xlink:to="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c97e2259-b631-4d7a-9cde-c29365449f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c97e2259-b631-4d7a-9cde-c29365449f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4346d264-0d0e-4f99-9b85-ac8d3fb90995" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c97e2259-b631-4d7a-9cde-c29365449f5c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4346d264-0d0e-4f99-9b85-ac8d3fb90995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a326aed0-ffaa-495e-98fa-b4e4e7fbb557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_4346d264-0d0e-4f99-9b85-ac8d3fb90995" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a326aed0-ffaa-495e-98fa-b4e4e7fbb557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_37cf53bf-ade4-4206-98a6-a54e24d2775a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_us-gaap_HedgingDesignationAxis_37cf53bf-ade4-4206-98a6-a54e24d2775a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a8939cfb-8fa1-4d20-97bc-926dffb216ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_37cf53bf-ade4-4206-98a6-a54e24d2775a" xlink:to="loc_us-gaap_HedgingDesignationDomain_a8939cfb-8fa1-4d20-97bc-926dffb216ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5a5024e8-00cc-484d-a013-b87a20c579fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_a8939cfb-8fa1-4d20-97bc-926dffb216ba" xlink:to="loc_us-gaap_NondesignatedMember_5a5024e8-00cc-484d-a013-b87a20c579fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_366203e1-87cc-4118-9530-698ff4aabc7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_366203e1-87cc-4118-9530-698ff4aabc7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c374c62d-3f79-4e69-95bc-140597f4052f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_366203e1-87cc-4118-9530-698ff4aabc7c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c374c62d-3f79-4e69-95bc-140597f4052f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_d0fe2eaa-6851-4b6c-ad48-40bdbb39b789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c374c62d-3f79-4e69-95bc-140597f4052f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_d0fe2eaa-6851-4b6c-ad48-40bdbb39b789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17afb161-18d0-4854-989f-4f86654a3058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17afb161-18d0-4854-989f-4f86654a3058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84ccb925-f9a5-461b-a6a7-8384120e01dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17afb161-18d0-4854-989f-4f86654a3058" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84ccb925-f9a5-461b-a6a7-8384120e01dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_a0d1682d-518e-4021-906f-851c43d057ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_84ccb925-f9a5-461b-a6a7-8384120e01dc" xlink:to="loc_us-gaap_AccountsReceivableMember_a0d1682d-518e-4021-906f-851c43d057ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_799b7ab3-5a81-48fd-a0ef-e63a1c27ce9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_srt_MajorCustomersAxis_799b7ab3-5a81-48fd-a0ef-e63a1c27ce9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_59e95137-a716-431a-a0b6-57739581b2d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_799b7ab3-5a81-48fd-a0ef-e63a1c27ce9b" xlink:to="loc_srt_NameOfMajorCustomerDomain_59e95137-a716-431a-a0b6-57739581b2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ThreeCustomersMember_56a70f3c-d066-4751-a5ae-7520d235a1f6" xlink:href="jazz-20220331.xsd#jazz_ThreeCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_59e95137-a716-431a-a0b6-57739581b2d7" xlink:to="loc_jazz_ThreeCustomersMember_56a70f3c-d066-4751-a5ae-7520d235a1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExpressScriptsMember_ead89e9c-a8dd-4f86-8001-0a503edfeac7" xlink:href="jazz-20220331.xsd#jazz_ExpressScriptsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_56a70f3c-d066-4751-a5ae-7520d235a1f6" xlink:to="loc_jazz_ExpressScriptsMember_ead89e9c-a8dd-4f86-8001-0a503edfeac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_McKessonCorporationMember_f78dcdd9-1b75-4d4f-8eaf-06f2118f2280" xlink:href="jazz-20220331.xsd#jazz_McKessonCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_56a70f3c-d066-4751-a5ae-7520d235a1f6" xlink:to="loc_jazz_McKessonCorporationMember_f78dcdd9-1b75-4d4f-8eaf-06f2118f2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CardinalHealthIncMember_f8cf945c-29bc-40f3-81a5-ed21ada1b9b8" xlink:href="jazz-20220331.xsd#jazz_CardinalHealthIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_56a70f3c-d066-4751-a5ae-7520d235a1f6" xlink:to="loc_jazz_CardinalHealthIncMember_f8cf945c-29bc-40f3-81a5-ed21ada1b9b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_0922ca98-9d84-4ab7-acc7-98d985d89cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b6e5d12c-b807-4d14-bb81-4956f84c31cb" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_0922ca98-9d84-4ab7-acc7-98d985d89cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_30171dc5-902e-4267-aad6-e4e12f77894b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0922ca98-9d84-4ab7-acc7-98d985d89cd6" xlink:to="loc_us-gaap_DerivativeNotionalAmount_30171dc5-902e-4267-aad6-e4e12f77894b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_fa31f324-8cfe-4d47-b080-00af798c038d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0922ca98-9d84-4ab7-acc7-98d985d89cd6" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_fa31f324-8cfe-4d47-b080-00af798c038d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_7d6f0fc8-4573-43d6-9f11-1ba01575f54d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_0922ca98-9d84-4ab7-acc7-98d985d89cd6" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_7d6f0fc8-4573-43d6-9f11-1ba01575f54d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="simple" xlink:href="jazz-20220331.xsd#CashandAvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_61e14dfa-76f1-49fd-94b1-8eda7ef57ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_39cbf67e-4cb7-4618-9f89-3f62b11cbd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_61e14dfa-76f1-49fd-94b1-8eda7ef57ed6" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_39cbf67e-4cb7-4618-9f89-3f62b11cbd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#CashandAvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1e0bbb85-d258-48b3-a412-bcd53b2f2c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1de4ca4e-a00b-4c5e-9b30-844d0f5a6b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1e0bbb85-d258-48b3-a412-bcd53b2f2c78" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1de4ca4e-a00b-4c5e-9b30-844d0f5a6b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d52043f-48dc-40cd-aac3-67d8cff86af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0dc57876-393c-4639-b818-461567e18b31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d52043f-48dc-40cd-aac3-67d8cff86af2" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0dc57876-393c-4639-b818-461567e18b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e7873e81-fd76-4a97-8185-6683fcb1ca79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0dc57876-393c-4639-b818-461567e18b31" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e7873e81-fd76-4a97-8185-6683fcb1ca79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_134d119b-689d-461b-8eed-b1195e56c29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e7873e81-fd76-4a97-8185-6683fcb1ca79" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_134d119b-689d-461b-8eed-b1195e56c29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_a64f1a02-408f-44b6-ae11-6bc90288f032" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_134d119b-689d-461b-8eed-b1195e56c29e" xlink:to="loc_us-gaap_CashMember_a64f1a02-408f-44b6-ae11-6bc90288f032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_fc568a40-2e1b-44fd-a71a-42e14f958d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_134d119b-689d-461b-8eed-b1195e56c29e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_fc568a40-2e1b-44fd-a71a-42e14f958d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_0dc57876-393c-4639-b818-461567e18b31" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cb754af5-7db4-41f0-9a31-3f3df55a5674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cb754af5-7db4-41f0-9a31-3f3df55a5674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_18ade474-e526-4081-924d-537ea12ff2f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_18ade474-e526-4081-924d-537ea12ff2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b5ff809b-f31f-43bb-b608-e4d4d591decf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b5ff809b-f31f-43bb-b608-e4d4d591decf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4fd10512-6d5a-4188-98e0-02140be54c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4fd10512-6d5a-4188-98e0-02140be54c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3449d551-3423-44eb-a5cd-2bdbfcf38c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2590db7f-2e6f-4ff0-9076-1838b2a2a3f3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3449d551-3423-44eb-a5cd-2bdbfcf38c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CashandAvailableforSaleSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3fd0407c-c380-48a5-97c2-5fd58189c199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a730e0b6-7ffd-4c19-8c00-efeb411004ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3fd0407c-c380-48a5-97c2-5fd58189c199" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a730e0b6-7ffd-4c19-8c00-efeb411004ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="jazz-20220331.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d4b765b7-aa82-42a6-b18d-4c4515f0064c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_54ae6db4-0dbd-4dd4-99b3-d214309b9791" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d4b765b7-aa82-42a6-b18d-4c4515f0064c" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_54ae6db4-0dbd-4dd4-99b3-d214309b9791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a5ed9ccc-384c-422b-9295-2ae5d3bf0e53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2eb86621-1275-41ca-9a8c-718e0fa853e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a5ed9ccc-384c-422b-9295-2ae5d3bf0e53" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2eb86621-1275-41ca-9a8c-718e0fa853e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5a627587-ade2-4283-88df-706d3f87696c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5a627587-ade2-4283-88df-706d3f87696c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d5dea24e-d053-4237-8cd2-d51c62e6965c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d5dea24e-d053-4237-8cd2-d51c62e6965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_09d0b3a8-5efd-418d-a353-9f90427b5782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d5dea24e-d053-4237-8cd2-d51c62e6965c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_09d0b3a8-5efd-418d-a353-9f90427b5782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_81378acf-f9fb-471c-b4bd-3c1b83904c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_09d0b3a8-5efd-418d-a353-9f90427b5782" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_81378acf-f9fb-471c-b4bd-3c1b83904c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca5a2f29-aece-4595-b738-51bd7fa7e43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca5a2f29-aece-4595-b738-51bd7fa7e43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6adc9b07-1c61-4c9d-be28-b30e23290baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ca5a2f29-aece-4595-b738-51bd7fa7e43e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6adc9b07-1c61-4c9d-be28-b30e23290baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_ecdadef6-9e6b-4d21-b8d0-7ee7133eb446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6adc9b07-1c61-4c9d-be28-b30e23290baa" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_ecdadef6-9e6b-4d21-b8d0-7ee7133eb446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_19bfae7e-528f-40e7-96f2-da7a9d103759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6adc9b07-1c61-4c9d-be28-b30e23290baa" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_19bfae7e-528f-40e7-96f2-da7a9d103759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cc668587-de6f-423d-bced-2c58e654f875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cc668587-de6f-423d-bced-2c58e654f875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_821a8c07-8d49-401f-981d-3093bd337901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cc668587-de6f-423d-bced-2c58e654f875" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_821a8c07-8d49-401f-981d-3093bd337901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_cb42f589-ac73-4706-b2d9-3be459137458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_821a8c07-8d49-401f-981d-3093bd337901" xlink:to="loc_us-gaap_MoneyMarketFundsMember_cb42f589-ac73-4706-b2d9-3be459137458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_c2abc965-1d3a-417f-9d33-92ae46d2cddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_821a8c07-8d49-401f-981d-3093bd337901" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_c2abc965-1d3a-417f-9d33-92ae46d2cddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_d1645c39-ad59-4995-99dd-fe5d7f74f3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_821a8c07-8d49-401f-981d-3093bd337901" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_d1645c39-ad59-4995-99dd-fe5d7f74f3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_65413ea4-cc26-4dd5-8fdd-fb439f7c7401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_23826c87-2bd6-4aca-8007-4670ebba81db" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_65413ea4-cc26-4dd5-8fdd-fb439f7c7401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_c795f1e5-e4ef-4b36-9e8d-cf0958d72bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_65413ea4-cc26-4dd5-8fdd-fb439f7c7401" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_c795f1e5-e4ef-4b36-9e8d-cf0958d72bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d8b57131-b7de-42f1-b7ba-c3c0255aff0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c795f1e5-e4ef-4b36-9e8d-cf0958d72bd3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d8b57131-b7de-42f1-b7ba-c3c0255aff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38f3ed84-4db3-4075-8965-da39bd50cb96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d8b57131-b7de-42f1-b7ba-c3c0255aff0f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_38f3ed84-4db3-4075-8965-da39bd50cb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_5e22716c-743c-4022-b11c-3ad103366325" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c795f1e5-e4ef-4b36-9e8d-cf0958d72bd3" xlink:to="loc_us-gaap_DerivativeAssets_5e22716c-743c-4022-b11c-3ad103366325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5da1960b-cc49-475f-a0ef-fd2f50847ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_c795f1e5-e4ef-4b36-9e8d-cf0958d72bd3" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_5da1960b-cc49-475f-a0ef-fd2f50847ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_388c8651-d3a4-44b8-a74c-a24972c1714c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_65413ea4-cc26-4dd5-8fdd-fb439f7c7401" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_388c8651-d3a4-44b8-a74c-a24972c1714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_8d1feb63-901c-4b2c-ae51-e349576f7f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_388c8651-d3a4-44b8-a74c-a24972c1714c" xlink:to="loc_us-gaap_DerivativeLiabilities_8d1feb63-901c-4b2c-ae51-e349576f7f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_270f2503-e9df-497b-b8f7-0dbba89455f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_388c8651-d3a4-44b8-a74c-a24972c1714c" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_270f2503-e9df-497b-b8f7-0dbba89455f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e64e7ea7-10b6-460c-9dd5-3e8487c87613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e64e7ea7-10b6-460c-9dd5-3e8487c87613" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7136cc2d-c11b-4c73-93f8-1d430182b772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7136cc2d-c11b-4c73-93f8-1d430182b772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbbb5d32-ceea-45bc-8028-1fd8b252f87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_7136cc2d-c11b-4c73-93f8-1d430182b772" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbbb5d32-ceea-45bc-8028-1fd8b252f87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b5f00548-ba7b-4700-b4f7-d1c9c2f7dd48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbbb5d32-ceea-45bc-8028-1fd8b252f87f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b5f00548-ba7b-4700-b4f7-d1c9c2f7dd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8635c098-d9e9-4b4b-8c4b-b1b07592d407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bbbb5d32-ceea-45bc-8028-1fd8b252f87f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8635c098-d9e9-4b4b-8c4b-b1b07592d407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c35f5e3e-a982-4545-94f0-ee7e8accd17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_us-gaap_DebtInstrumentAxis_c35f5e3e-a982-4545-94f0-ee7e8accd17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c35f5e3e-a982-4545-94f0-ee7e8accd17a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_46cc249c-0290-4201-93cb-5758f2d52ebc" xlink:href="jazz-20220331.xsd#jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_46cc249c-0290-4201-93cb-5758f2d52ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_ba37b495-92b8-4f0d-b3ca-464825fb2a79" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_ba37b495-92b8-4f0d-b3ca-464825fb2a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_e49cf47e-a454-420d-9401-17c7be91f80b" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_e49cf47e-a454-420d-9401-17c7be91f80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_52a1e08e-3d8a-4256-8a9d-4c8b2660ba3f" xlink:href="jazz-20220331.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_41784677-c3a1-4f3c-a0c9-86bce592ecb9" xlink:to="loc_jazz_SeniorNotesDue2029Member_52a1e08e-3d8a-4256-8a9d-4c8b2660ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b55a6559-2fdc-46a3-960f-5bdcf16937de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b55a6559-2fdc-46a3-960f-5bdcf16937de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e9a6c30d-9b16-48d7-8ede-bbdfa498ae49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b55a6559-2fdc-46a3-960f-5bdcf16937de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e9a6c30d-9b16-48d7-8ede-bbdfa498ae49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_335bb13d-94aa-493d-be43-62f0ac8e0c62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e9a6c30d-9b16-48d7-8ede-bbdfa498ae49" xlink:to="loc_us-gaap_ConvertibleDebtMember_335bb13d-94aa-493d-be43-62f0ac8e0c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorSecuredDebtMember_ef7c5c9e-bf9f-4c60-a29a-a2b9400e7541" xlink:href="jazz-20220331.xsd#jazz_SeniorSecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e9a6c30d-9b16-48d7-8ede-bbdfa498ae49" xlink:to="loc_jazz_SeniorSecuredDebtMember_ef7c5c9e-bf9f-4c60-a29a-a2b9400e7541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_e1ef7589-ab04-447d-8c99-7aa54c6c8d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e9a6c30d-9b16-48d7-8ede-bbdfa498ae49" xlink:to="loc_us-gaap_LineOfCreditMember_e1ef7589-ab04-447d-8c99-7aa54c6c8d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3d318a47-140a-4a2c-b467-2782be5f6e1a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_dei_LegalEntityAxis_3d318a47-140a-4a2c-b467-2782be5f6e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0747a2fd-d79c-41d1-a223-974f722a2f42" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3d318a47-140a-4a2c-b467-2782be5f6e1a" xlink:to="loc_dei_EntityDomain_0747a2fd-d79c-41d1-a223-974f722a2f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_c90fc4f7-5fc8-4c42-bf36-592a1d5a6e47" xlink:href="jazz-20220331.xsd#jazz_JazzSecuritiesDesignatedActivityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0747a2fd-d79c-41d1-a223-974f722a2f42" xlink:to="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_c90fc4f7-5fc8-4c42-bf36-592a1d5a6e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e4860135-f69c-438d-82aa-a61f24b1b913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_us-gaap_CreditFacilityAxis_e4860135-f69c-438d-82aa-a61f24b1b913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c3e06557-4e92-4ed3-86ac-605a9ab824c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e4860135-f69c-438d-82aa-a61f24b1b913" xlink:to="loc_us-gaap_CreditFacilityDomain_c3e06557-4e92-4ed3-86ac-605a9ab824c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8dafcf89-33de-4a1f-9119-3683d929ebd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_c3e06557-4e92-4ed3-86ac-605a9ab824c6" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8dafcf89-33de-4a1f-9119-3683d929ebd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_24db7e44-96b9-44d8-ab2c-a770b3cc551e" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15fb5175-3a7c-45e5-91f1-21dcca2c7e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_15fb5175-3a7c-45e5-91f1-21dcca2c7e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251a5be6-6ad3-40e3-9fdd-f0797dfdefb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_251a5be6-6ad3-40e3-9fdd-f0797dfdefb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c93008bf-2e63-475c-a426-b987b72d4489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_DebtInstrumentTerm_c93008bf-2e63-475c-a426-b987b72d4489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e933a86d-2239-4043-8e8c-885ec242c911" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e933a86d-2239-4043-8e8c-885ec242c911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_dc7f57df-e8aa-46b5-9305-c334f3836674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_dc7f57df-e8aa-46b5-9305-c334f3836674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_b70259b4-e779-481e-9b0e-90ce49c53487" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_b70259b4-e779-481e-9b0e-90ce49c53487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_e8691db9-098b-43da-83fe-4fa4fa9b0e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_e8691db9-098b-43da-83fe-4fa4fa9b0e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fc07a0e8-fdf7-4ee3-83dc-f8c047dd3cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_0992d3c4-9c03-400c-903a-43fd387914c5" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fc07a0e8-fdf7-4ee3-83dc-f8c047dd3cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5d78ba69-7fa7-43b7-b186-65213b67e838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c2d2585d-70ae-49e1-b2e6-7fd8997b1987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5d78ba69-7fa7-43b7-b186-65213b67e838" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_c2d2585d-70ae-49e1-b2e6-7fd8997b1987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ca902e46-1786-4570-9e65-0a7e3fc1e711" xlink:href="jazz-20220331.xsd#jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ca902e46-1786-4570-9e65-0a7e3fc1e711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7b985a31-1a2c-4ece-9e9f-f3e3caf88553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7b985a31-1a2c-4ece-9e9f-f3e3caf88553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_66309b78-b0cc-4aa7-b8d9-76fe3ee49335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_66309b78-b0cc-4aa7-b8d9-76fe3ee49335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8fa23cc9-64b4-4eb6-8dfd-fa23fd6271cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8fa23cc9-64b4-4eb6-8dfd-fa23fd6271cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_b1948477-233a-470d-bf30-ee66d4244c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_b1948477-233a-470d-bf30-ee66d4244c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_4c172e77-7784-42fd-9454-621f59f22206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8f7107e2-e3ce-45ec-9093-c2d4c3854dcd" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_4c172e77-7784-42fd-9454-621f59f22206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_33974e98-9052-49f4-a285-cef609baab55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4b1786e4-a09f-4cf8-9665-d315d3238c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_33974e98-9052-49f4-a285-cef609baab55" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4b1786e4-a09f-4cf8-9665-d315d3238c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9d89c5f5-933e-4bd7-bed2-eab64889a1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4b1786e4-a09f-4cf8-9665-d315d3238c93" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9d89c5f5-933e-4bd7-bed2-eab64889a1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f2b071b2-821c-446b-86a1-2e53555091d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9d89c5f5-933e-4bd7-bed2-eab64889a1b7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f2b071b2-821c-446b-86a1-2e53555091d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_84b002df-5e9d-4c2b-9448-dfa805a34c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_f2b071b2-821c-446b-86a1-2e53555091d2" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_84b002df-5e9d-4c2b-9448-dfa805a34c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ca2beab6-4942-42cb-b6dc-45af7f7c51a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4b1786e4-a09f-4cf8-9665-d315d3238c93" xlink:to="loc_us-gaap_HedgingDesignationAxis_ca2beab6-4942-42cb-b6dc-45af7f7c51a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fe707efd-8e78-4cd4-9603-cfbbd19add7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ca2beab6-4942-42cb-b6dc-45af7f7c51a5" xlink:to="loc_us-gaap_HedgingDesignationDomain_fe707efd-8e78-4cd4-9603-cfbbd19add7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_95e241d9-a864-4460-84ad-81365f639015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fe707efd-8e78-4cd4-9603-cfbbd19add7a" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_95e241d9-a864-4460-84ad-81365f639015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_66d468d7-39c5-45d2-a7b0-f8fc5d8e0c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4b1786e4-a09f-4cf8-9665-d315d3238c93" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_66d468d7-39c5-45d2-a7b0-f8fc5d8e0c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_399557ef-fb3b-4463-a5c2-9d4d2fe620b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_66d468d7-39c5-45d2-a7b0-f8fc5d8e0c0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_399557ef-fb3b-4463-a5c2-9d4d2fe620b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_ec08a09b-6d2d-4835-af31-66e019ff134b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_66d468d7-39c5-45d2-a7b0-f8fc5d8e0c0e" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_ec08a09b-6d2d-4835-af31-66e019ff134b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d62e507-4968-42fe-883e-d066b38cfe76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_264085f4-8d52-443f-a33e-5db8eaca2aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9d62e507-4968-42fe-883e-d066b38cfe76" xlink:to="loc_us-gaap_DerivativeTable_264085f4-8d52-443f-a33e-5db8eaca2aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_af850e35-1cde-476c-91db-f21032d00480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_264085f4-8d52-443f-a33e-5db8eaca2aa5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_af850e35-1cde-476c-91db-f21032d00480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_212e48fe-2817-470b-86fa-64564ab99849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_af850e35-1cde-476c-91db-f21032d00480" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_212e48fe-2817-470b-86fa-64564ab99849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1ae17f10-7c1f-4a48-82c4-6b5d2edea093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_212e48fe-2817-470b-86fa-64564ab99849" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1ae17f10-7c1f-4a48-82c4-6b5d2edea093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_543eb7cb-f1bc-470f-973d-d720e2aa2cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_264085f4-8d52-443f-a33e-5db8eaca2aa5" xlink:to="loc_us-gaap_HedgingDesignationAxis_543eb7cb-f1bc-470f-973d-d720e2aa2cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ec27df93-76c7-4f2e-a4e9-aa8a5c9ff1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_543eb7cb-f1bc-470f-973d-d720e2aa2cdb" xlink:to="loc_us-gaap_HedgingDesignationDomain_ec27df93-76c7-4f2e-a4e9-aa8a5c9ff1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ec8913a2-4d99-45cd-adea-b46e9185a61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ec27df93-76c7-4f2e-a4e9-aa8a5c9ff1e5" xlink:to="loc_us-gaap_NondesignatedMember_ec8913a2-4d99-45cd-adea-b46e9185a61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_14110836-ef07-451f-a335-20384bb44549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_264085f4-8d52-443f-a33e-5db8eaca2aa5" xlink:to="loc_us-gaap_DerivativeLineItems_14110836-ef07-451f-a335-20384bb44549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_b4ceb97d-6b40-4ec0-bed0-f1741b4bbf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_14110836-ef07-451f-a335-20384bb44549" xlink:to="loc_us-gaap_DerivativeNotionalAmount_b4ceb97d-6b40-4ec0-bed0-f1741b4bbf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_486e9843-7c33-43c6-8373-73355a20937c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_f82ea7ff-b9bb-47da-ab14-6470114bf61d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_486e9843-7c33-43c6-8373-73355a20937c" xlink:to="loc_us-gaap_DerivativeTable_f82ea7ff-b9bb-47da-ab14-6470114bf61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bd7ec404-4ca0-4717-a40f-f293d85bc489" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f82ea7ff-b9bb-47da-ab14-6470114bf61d" xlink:to="loc_us-gaap_HedgingDesignationAxis_bd7ec404-4ca0-4717-a40f-f293d85bc489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8b149e16-94eb-4015-9947-ad81422ba9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_bd7ec404-4ca0-4717-a40f-f293d85bc489" xlink:to="loc_us-gaap_HedgingDesignationDomain_8b149e16-94eb-4015-9947-ad81422ba9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_3c342159-d048-4038-8a03-ace8bc74b963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8b149e16-94eb-4015-9947-ad81422ba9d8" xlink:to="loc_us-gaap_NondesignatedMember_3c342159-d048-4038-8a03-ace8bc74b963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4e040a6e-d9ee-439b-8e19-5f365dca3e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f82ea7ff-b9bb-47da-ab14-6470114bf61d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4e040a6e-d9ee-439b-8e19-5f365dca3e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_038a2c90-806c-4ec3-95ff-d2ffd199c301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4e040a6e-d9ee-439b-8e19-5f365dca3e4d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_038a2c90-806c-4ec3-95ff-d2ffd199c301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_c72a54bd-fdc8-42c0-a452-bc7843151a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_038a2c90-806c-4ec3-95ff-d2ffd199c301" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_c72a54bd-fdc8-42c0-a452-bc7843151a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_51125505-762a-4f24-9991-c1fc5874d452" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_f82ea7ff-b9bb-47da-ab14-6470114bf61d" xlink:to="loc_us-gaap_DerivativeLineItems_51125505-762a-4f24-9991-c1fc5874d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5422b8ae-3fcc-41c3-bf4c-1cf434dd5f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_51125505-762a-4f24-9991-c1fc5874d452" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5422b8ae-3fcc-41c3-bf4c-1cf434dd5f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4184dcc9-60fa-493a-988e-a74d8990f43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_25ed43b0-a98c-4aa4-8bca-8167f077c0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4184dcc9-60fa-493a-988e-a74d8990f43a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_25ed43b0-a98c-4aa4-8bca-8167f077c0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_de522e39-22e7-4898-81c2-c6f2159b370c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_25ed43b0-a98c-4aa4-8bca-8167f077c0a7" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_de522e39-22e7-4898-81c2-c6f2159b370c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0f33f86f-cb95-45f4-ba42-fdecfb88e7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_de522e39-22e7-4898-81c2-c6f2159b370c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0f33f86f-cb95-45f4-ba42-fdecfb88e7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_cb0da442-3ff9-47b2-9ce5-15152ec2d9c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0f33f86f-cb95-45f4-ba42-fdecfb88e7b0" xlink:to="loc_us-gaap_InterestRateContractMember_cb0da442-3ff9-47b2-9ce5-15152ec2d9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e107e4de-d529-46f3-9bcc-f5b7c25ccbd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_25ed43b0-a98c-4aa4-8bca-8167f077c0a7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e107e4de-d529-46f3-9bcc-f5b7c25ccbd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_905232ed-6def-47db-9c53-9474d389a5b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e107e4de-d529-46f3-9bcc-f5b7c25ccbd7" xlink:to="loc_us-gaap_HedgingRelationshipDomain_905232ed-6def-47db-9c53-9474d389a5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_28c21fef-1100-46e4-911c-a27f073cc61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_905232ed-6def-47db-9c53-9474d389a5b2" xlink:to="loc_us-gaap_CashFlowHedgingMember_28c21fef-1100-46e4-911c-a27f073cc61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c7c3f84b-0652-45e7-a304-5eed2db75df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_25ed43b0-a98c-4aa4-8bca-8167f077c0a7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c7c3f84b-0652-45e7-a304-5eed2db75df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6c3e1ca4-36c4-413d-8d12-3328e02f6f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c7c3f84b-0652-45e7-a304-5eed2db75df2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_6c3e1ca4-36c4-413d-8d12-3328e02f6f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e4a0568b-db93-40d3-9c6c-2ba17a8d83a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_c7c3f84b-0652-45e7-a304-5eed2db75df2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_e4a0568b-db93-40d3-9c6c-2ba17a8d83a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4106ce48-bf2c-40b4-8c6b-05df3036cfc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4106ce48-bf2c-40b4-8c6b-05df3036cfc1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_e182f19d-9c75-439f-853c-18073d91ea66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:to="loc_us-gaap_HedgingDesignationAxis_e182f19d-9c75-439f-853c-18073d91ea66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b9059870-50ea-44b0-af3f-c5bba5658abf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_e182f19d-9c75-439f-853c-18073d91ea66" xlink:to="loc_us-gaap_HedgingDesignationDomain_b9059870-50ea-44b0-af3f-c5bba5658abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_87713838-5e98-413e-ab04-8b7f20d813b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b9059870-50ea-44b0-af3f-c5bba5658abf" xlink:to="loc_us-gaap_NondesignatedMember_87713838-5e98-413e-ab04-8b7f20d813b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fbf14702-48f7-406b-ba37-fc8279b83690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_b9059870-50ea-44b0-af3f-c5bba5658abf" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fbf14702-48f7-406b-ba37-fc8279b83690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_21e3edf5-ffc1-4549-9dc7-d75c185defb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_21e3edf5-ffc1-4549-9dc7-d75c185defb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ee13e004-f12f-4959-9798-29f81902f17b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_21e3edf5-ffc1-4549-9dc7-d75c185defb0" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ee13e004-f12f-4959-9798-29f81902f17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_77a856a3-1d52-4526-bab1-56b07ab5cef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee13e004-f12f-4959-9798-29f81902f17b" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_77a856a3-1d52-4526-bab1-56b07ab5cef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_1a9e954e-4ec0-4783-a3fe-2387a21b6d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ee13e004-f12f-4959-9798-29f81902f17b" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_1a9e954e-4ec0-4783-a3fe-2387a21b6d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_67878bf7-84ca-4574-808a-1ee0c3ae0fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_67878bf7-84ca-4574-808a-1ee0c3ae0fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cf5a2c0c-55d9-415c-b862-2b4b5b71a046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_67878bf7-84ca-4574-808a-1ee0c3ae0fcc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cf5a2c0c-55d9-415c-b862-2b4b5b71a046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_ee495779-755e-4534-a541-28b284806b83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cf5a2c0c-55d9-415c-b862-2b4b5b71a046" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_ee495779-755e-4534-a541-28b284806b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_10f169f8-6e03-440e-9bb1-fd3242ae41f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cf5a2c0c-55d9-415c-b862-2b4b5b71a046" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_10f169f8-6e03-440e-9bb1-fd3242ae41f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_b3d78958-0139-4e20-8bb8-bc40e3b1533c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d421cbed-891d-4a05-8f61-5de485f03f81" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_b3d78958-0139-4e20-8bb8-bc40e3b1533c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_b7411ca2-8646-49ff-90e8-3deb3fd7dd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b3d78958-0139-4e20-8bb8-bc40e3b1533c" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_b7411ca2-8646-49ff-90e8-3deb3fd7dd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_41f936b0-825f-4e55-8e10-f2e0df3ad4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_b3d78958-0139-4e20-8bb8-bc40e3b1533c" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_41f936b0-825f-4e55-8e10-f2e0df3ad4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_287cdbeb-721f-4697-a10c-de73e6aabcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_a5473f6e-8417-4219-9ea2-885fdc51f5de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_287cdbeb-721f-4697-a10c-de73e6aabcc4" xlink:to="loc_us-gaap_OffsettingAssetsTable_a5473f6e-8417-4219-9ea2-885fdc51f5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_5ab8bf97-8521-425f-a930-52c96ac78f4b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a5473f6e-8417-4219-9ea2-885fdc51f5de" xlink:to="loc_srt_StatementScenarioAxis_5ab8bf97-8521-425f-a930-52c96ac78f4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c275b164-9ce7-49d4-a313-eb9f6fb3278e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_5ab8bf97-8521-425f-a930-52c96ac78f4b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c275b164-9ce7-49d4-a313-eb9f6fb3278e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_7c88f830-753f-4f4a-9b89-c9ec5c126533" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c275b164-9ce7-49d4-a313-eb9f6fb3278e" xlink:to="loc_srt_ProFormaMember_7c88f830-753f-4f4a-9b89-c9ec5c126533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_408e9207-0cf5-422a-99bf-591f8bc954d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_a5473f6e-8417-4219-9ea2-885fdc51f5de" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_408e9207-0cf5-422a-99bf-591f8bc954d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_640d8f77-0122-447d-a5bb-2fdb749bb3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_408e9207-0cf5-422a-99bf-591f8bc954d4" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_640d8f77-0122-447d-a5bb-2fdb749bb3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_410692a2-cb27-4afe-9622-54faed38c26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_640d8f77-0122-447d-a5bb-2fdb749bb3ef" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_410692a2-cb27-4afe-9622-54faed38c26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_9a954de8-38e6-49fc-ab91-4ca95bd96704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_640d8f77-0122-447d-a5bb-2fdb749bb3ef" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_9a954de8-38e6-49fc-ab91-4ca95bd96704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_1cdae1d1-d285-4a20-8f62-aa5c51b38ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_640d8f77-0122-447d-a5bb-2fdb749bb3ef" xlink:to="loc_us-gaap_DerivativeAssets_1cdae1d1-d285-4a20-8f62-aa5c51b38ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_48d55acd-f30d-4c7f-bfbd-cb5d54546439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_408e9207-0cf5-422a-99bf-591f8bc954d4" xlink:to="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_48d55acd-f30d-4c7f-bfbd-cb5d54546439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_3f3d8245-55a5-4025-bb31-665baebbaa43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_48d55acd-f30d-4c7f-bfbd-cb5d54546439" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_3f3d8245-55a5-4025-bb31-665baebbaa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_26547816-b639-475d-9e92-3c67d7b19ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_48d55acd-f30d-4c7f-bfbd-cb5d54546439" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_26547816-b639-475d-9e92-3c67d7b19ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_7dc718bf-80d8-4141-818b-ac4abbea70fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_48d55acd-f30d-4c7f-bfbd-cb5d54546439" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_7dc718bf-80d8-4141-818b-ac4abbea70fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTable_a9ca112e-7547-4f37-84af-b95042d0aa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_287cdbeb-721f-4697-a10c-de73e6aabcc4" xlink:to="loc_us-gaap_OffsettingLiabilitiesTable_a9ca112e-7547-4f37-84af-b95042d0aa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_2a47464b-9152-4a54-ae71-e17a65ea2dcd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesTable_a9ca112e-7547-4f37-84af-b95042d0aa3b" xlink:to="loc_srt_StatementScenarioAxis_2a47464b-9152-4a54-ae71-e17a65ea2dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_bf341006-6778-43df-9418-296d2cc4cfcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_db6211ad-3ed4-4875-922a-618d4f065f06" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesLineItems_93f019e2-b976-4d98-94b3-4b1277955bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesTable_a9ca112e-7547-4f37-84af-b95042d0aa3b" xlink:to="loc_us-gaap_OffsettingLiabilitiesLineItems_93f019e2-b976-4d98-94b3-4b1277955bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_392237ff-82fc-4597-91e9-76b237cd0621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesLineItems_93f019e2-b976-4d98-94b3-4b1277955bee" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_392237ff-82fc-4597-91e9-76b237cd0621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87b81ea4-a2bd-4702-a3ef-eaa8e5db501e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_392237ff-82fc-4597-91e9-76b237cd0621" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_87b81ea4-a2bd-4702-a3ef-eaa8e5db501e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_2a4743e5-b9f8-4028-9e7e-70afae3cb82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_392237ff-82fc-4597-91e9-76b237cd0621" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_2a4743e5-b9f8-4028-9e7e-70afae3cb82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5f281341-741d-47b4-9716-62449d80de77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_392237ff-82fc-4597-91e9-76b237cd0621" xlink:to="loc_us-gaap_DerivativeLiabilities_5f281341-741d-47b4-9716-62449d80de77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_8d24786c-6309-45b7-8de0-d455f96e5759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesLineItems_93f019e2-b976-4d98-94b3-4b1277955bee" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_8d24786c-6309-45b7-8de0-d455f96e5759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_91ec7346-aadc-45dc-8418-4014a99dac51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_8d24786c-6309-45b7-8de0-d455f96e5759" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_91ec7346-aadc-45dc-8418-4014a99dac51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_9195c899-45f0-497e-b604-c88fb72e63dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_8d24786c-6309-45b7-8de0-d455f96e5759" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_9195c899-45f0-497e-b604-c88fb72e63dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f77ce40d-9512-4c1c-a55d-fbf6f5d07770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_8d24786c-6309-45b7-8de0-d455f96e5759" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_f77ce40d-9512-4c1c-a55d-fbf6f5d07770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Inventories" xlink:type="simple" xlink:href="jazz-20220331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c4b3733c-a0f6-48c1-a380-66854b214f20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_4268f58f-35c7-42e1-a92e-b248acbf2cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c4b3733c-a0f6-48c1-a380-66854b214f20" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_4268f58f-35c7-42e1-a92e-b248acbf2cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c1d0ad99-3eed-44b3-8e01-a1f60951db68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0a899e9a-7f1b-4185-b325-bc057a42f8fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c1d0ad99-3eed-44b3-8e01-a1f60951db68" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0a899e9a-7f1b-4185-b325-bc057a42f8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#InventoriesComponentsofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6640ae23-569b-4624-bbdf-fffde30d7dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_19aeb583-6eef-437f-8744-ad49e600cb64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6640ae23-569b-4624-bbdf-fffde30d7dff" xlink:to="loc_us-gaap_InventoryCurrentTable_19aeb583-6eef-437f-8744-ad49e600cb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4cef22bd-b42b-4b2a-828b-f76ae8b0a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_19aeb583-6eef-437f-8744-ad49e600cb64" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4cef22bd-b42b-4b2a-828b-f76ae8b0a72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09c52b0c-62fe-4850-b936-e1e1a0d5dbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4cef22bd-b42b-4b2a-828b-f76ae8b0a72b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09c52b0c-62fe-4850-b936-e1e1a0d5dbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_b23b79ca-5a67-462e-a383-a5a65ea071c2" xlink:href="jazz-20220331.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09c52b0c-62fe-4850-b936-e1e1a0d5dbaf" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_b23b79ca-5a67-462e-a383-a5a65ea071c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_19aeb583-6eef-437f-8744-ad49e600cb64" xlink:to="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_afd3a0b1-89cd-4943-946d-c715802df8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_afd3a0b1-89cd-4943-946d-c715802df8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3d20add3-5e4f-4733-b1dd-9721416f6ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3d20add3-5e4f-4733-b1dd-9721416f6ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3ba6af1c-1922-4969-ac5b-703905b69605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3ba6af1c-1922-4969-ac5b-703905b69605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3b9d51fb-9748-4d22-ba8a-54ab674de648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:to="loc_us-gaap_InventoryNet_3b9d51fb-9748-4d22-ba8a-54ab674de648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InventoryStepUpValue_0ec296d6-fdd8-4ec0-b621-274616359ff7" xlink:href="jazz-20220331.xsd#jazz_InventoryStepUpValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_c22f9de1-9ec8-4f6e-beb2-065177ac7aad" xlink:to="loc_jazz_InventoryStepUpValue_0ec296d6-fdd8-4ec0-b621-274616359ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="jazz-20220331.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35e8f4c5-4c6a-417c-a51d-abbcd771de24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1dc2a9a8-9d07-4ede-ae18-6c0f0e6a2a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_35e8f4c5-4c6a-417c-a51d-abbcd771de24" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_1dc2a9a8-9d07-4ede-ae18-6c0f0e6a2a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c189752-43db-4cd9-b1e0-ff291bdf65b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_7b148a4d-eed5-4c33-a067-334f18947bf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c189752-43db-4cd9-b1e0-ff291bdf65b1" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_7b148a4d-eed5-4c33-a067-334f18947bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_8e19d8b8-c9e1-42ca-b296-78db064e9619" xlink:href="jazz-20220331.xsd#jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c189752-43db-4cd9-b1e0-ff291bdf65b1" xlink:to="loc_jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_8e19d8b8-c9e1-42ca-b296-78db064e9619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_14035c56-c5a1-482d-8556-8bb649841476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4c189752-43db-4cd9-b1e0-ff291bdf65b1" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_14035c56-c5a1-482d-8556-8bb649841476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#GoodwillandIntangibleAssetsGoodwillActivityDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d4fe1702-6eb5-4301-8530-067bde06d09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d4fe1702-6eb5-4301-8530-067bde06d09a" xlink:to="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b8db993a-9be1-47b7-8cad-eb6306861f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:to="loc_us-gaap_Goodwill_b8db993a-9be1-47b7-8cad-eb6306861f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_8b6a06ae-6bd8-4faf-a1c7-c1a1e5c62162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_8b6a06ae-6bd8-4faf-a1c7-c1a1e5c62162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_98a189bb-0af2-4032-84e1-5fd7beee4a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_98a189bb-0af2-4032-84e1-5fd7beee4a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6dfa4418-db84-4f31-97d1-e7deef061a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_94308b8d-f015-4bc5-8e51-ea3e77f5f595" xlink:to="loc_us-gaap_Goodwill_6dfa4418-db84-4f31-97d1-e7deef061a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9f8f04d-8b91-4c84-8db6-896e2d8b73a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7c560ad-27a4-43fc-a679-32e5116aa688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9f8f04d-8b91-4c84-8db6-896e2d8b73a9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7c560ad-27a4-43fc-a679-32e5116aa688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_11c5240b-bfcc-4d07-ab57-fb6ee3c7c0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7c560ad-27a4-43fc-a679-32e5116aa688" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_11c5240b-bfcc-4d07-ab57-fb6ee3c7c0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd4842d3-933e-4136-95ac-7eb8fe5564e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_11c5240b-bfcc-4d07-ab57-fb6ee3c7c0fa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd4842d3-933e-4136-95ac-7eb8fe5564e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9816cb07-1d16-4d2c-8060-315b8d6de0ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd4842d3-933e-4136-95ac-7eb8fe5564e0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9816cb07-1d16-4d2c-8060-315b8d6de0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ManufacturingContractsMember_31537976-2a81-4578-b9e8-e1bcb778cadf" xlink:href="jazz-20220331.xsd#jazz_ManufacturingContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd4842d3-933e-4136-95ac-7eb8fe5564e0" xlink:to="loc_jazz_ManufacturingContractsMember_31537976-2a81-4578-b9e8-e1bcb778cadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_4d96abd2-9963-4513-a24e-4279f06b0b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bd4842d3-933e-4136-95ac-7eb8fe5564e0" xlink:to="loc_us-gaap_TrademarksMember_4d96abd2-9963-4513-a24e-4279f06b0b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8ee328d-20cb-456d-8e6e-ee5e96fd2164" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7c560ad-27a4-43fc-a679-32e5116aa688" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8ee328d-20cb-456d-8e6e-ee5e96fd2164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3dab1f5-183d-4c7c-9857-7a7a474dca8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_f8ee328d-20cb-456d-8e6e-ee5e96fd2164" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3dab1f5-183d-4c7c-9857-7a7a474dca8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_529bf41d-5eae-4147-8c11-30e43b44ca0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b3dab1f5-183d-4c7c-9857-7a7a474dca8f" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_529bf41d-5eae-4147-8c11-30e43b44ca0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c7c560ad-27a4-43fc-a679-32e5116aa688" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_abd9a5a5-21d2-48e5-b293-8fe2deaedc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_abd9a5a5-21d2-48e5-b293-8fe2deaedc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c25657bd-c750-44b9-a1cf-97ca9a4c5f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_c25657bd-c750-44b9-a1cf-97ca9a4c5f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f69e5a41-1a5a-4c88-a731-2074dc45315e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f69e5a41-1a5a-4c88-a731-2074dc45315e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b6ff6d4f-a1ad-410a-bcbe-82997e90981a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b6ff6d4f-a1ad-410a-bcbe-82997e90981a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b875b4e4-4cfd-48fd-bf3c-a3a20f7c5b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_b875b4e4-4cfd-48fd-bf3c-a3a20f7c5b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1952a352-94d5-434e-83de-6f63860b7ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_1952a352-94d5-434e-83de-6f63860b7ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1be585e6-f38c-441d-adfa-127400187fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1222273a-ccb0-40a2-ae31-1ca7236cb762" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1be585e6-f38c-441d-adfa-127400187fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ef0c311f-ae87-42bc-a36a-010d09c5c35f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ef0c311f-ae87-42bc-a36a-010d09c5c35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bfdfcec3-fa8d-458e-9b1d-b8b75b012eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bfdfcec3-fa8d-458e-9b1d-b8b75b012eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ddecb6-526b-400d-b92e-af4225087f86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_32ddecb6-526b-400d-b92e-af4225087f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_718bb5f6-98bd-4bbd-8300-1ddcd377ec29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_718bb5f6-98bd-4bbd-8300-1ddcd377ec29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_656af703-4c58-4a27-b267-ecf7909e5bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_656af703-4c58-4a27-b267-ecf7909e5bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_b6cf45af-8409-43a7-a5b5-ee8c840aa720" xlink:href="jazz-20220331.xsd#jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_b6cf45af-8409-43a7-a5b5-ee8c840aa720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91fa76ef-64ee-41ee-99bd-acd1c88a884d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9577814-246e-463d-a8aa-a2355ff62ab2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_91fa76ef-64ee-41ee-99bd-acd1c88a884d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="simple" xlink:href="jazz-20220331.xsd#CertainBalanceSheetItems"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_d0868ad0-fa75-479e-88f9-a3a6f7f85873" xlink:href="jazz-20220331.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b19eac79-e413-4f59-a93f-da267a0c8d2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_d0868ad0-fa75-479e-88f9-a3a6f7f85873" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b19eac79-e413-4f59-a93f-da267a0c8d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#CertainBalanceSheetItemsTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_eb53467f-75d4-4501-b922-26b3eec881a1" xlink:href="jazz-20220331.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5078bb98-965c-4b28-9f70-f1680f4b7d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_eb53467f-75d4-4501-b922-26b3eec881a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_5078bb98-965c-4b28-9f70-f1680f4b7d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ecb1f435-1a13-4b5c-9ea4-2f845d3801bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_eb53467f-75d4-4501-b922-26b3eec881a1" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_ecb1f435-1a13-4b5c-9ea4-2f845d3801bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e14f979d-21de-48c0-9bfc-285c106a8653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_eb53467f-75d4-4501-b922-26b3eec881a1" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e14f979d-21de-48c0-9bfc-285c106a8653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CertainBalanceSheetItemsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_38a24e00-0a03-46f8-9fea-c91617ece07a" xlink:href="jazz-20220331.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6c98b82-98a9-4f20-8a7a-fa66645fe1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_38a24e00-0a03-46f8-9fea-c91617ece07a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6c98b82-98a9-4f20-8a7a-fa66645fe1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c986806f-74b6-4d06-bde3-1323e2317538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6c98b82-98a9-4f20-8a7a-fa66645fe1fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c986806f-74b6-4d06-bde3-1323e2317538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c986806f-74b6-4d06-bde3-1323e2317538" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_7c5804e7-bf1e-4263-b263-e045f4027f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_ConstructionInProgressMember_7c5804e7-bf1e-4263-b263-e045f4027f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_edf7364d-ed20-4dbf-aee3-178fe5769ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_edf7364d-ed20-4dbf-aee3-178fe5769ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_32e9c9bb-139e-43e7-9923-3bf9437d9e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_32e9c9bb-139e-43e7-9923-3bf9437d9e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndBuildingMember_8df16429-b134-4e8b-a118-921645b2ed1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndBuildingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_LandAndBuildingMember_8df16429-b134-4e8b-a118-921645b2ed1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da81c080-fd92-4f46-a334-13896dff8042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_da81c080-fd92-4f46-a334-13896dff8042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_9e1176b7-f315-4f73-add5-c7eaf768e009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_ComputerEquipmentMember_9e1176b7-f315-4f73-add5-c7eaf768e009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_fefb51ff-5d67-48b5-8143-c50356a6b598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0b0b79e7-16e9-429d-92f1-3bff5b72c0bf" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_fefb51ff-5d67-48b5-8143-c50356a6b598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ead84085-e88e-45d8-8130-de166285e8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c6c98b82-98a9-4f20-8a7a-fa66645fe1fa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ead84085-e88e-45d8-8130-de166285e8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b44577fd-50a0-420f-ac3f-b39249273906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ead84085-e88e-45d8-8130-de166285e8e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_b44577fd-50a0-420f-ac3f-b39249273906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_418aaeb6-b5a9-48c9-b39f-9eae596d2c56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ead84085-e88e-45d8-8130-de166285e8e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_418aaeb6-b5a9-48c9-b39f-9eae596d2c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c9bed4f6-3475-4f4b-ab7f-f0f12009ffca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ead84085-e88e-45d8-8130-de166285e8e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c9bed4f6-3475-4f4b-ab7f-f0f12009ffca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CertainBalanceSheetItemsOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_9abeeab4-412f-459e-8520-f5b17f6618c3" xlink:href="jazz-20220331.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxIntercompanyProfitCurrent_02e3ae00-d552-4e17-9c48-dd049dc6be4f" xlink:href="jazz-20220331.xsd#jazz_DeferredTaxIntercompanyProfitCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_9abeeab4-412f-459e-8520-f5b17f6618c3" xlink:to="loc_jazz_DeferredTaxIntercompanyProfitCurrent_02e3ae00-d552-4e17-9c48-dd049dc6be4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_7035586c-6766-4915-959e-6f4bb770a9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_9abeeab4-412f-459e-8520-f5b17f6618c3" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_7035586c-6766-4915-959e-6f4bb770a9d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c93321d4-b75b-48e0-a377-ff7869e210c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_9abeeab4-412f-459e-8520-f5b17f6618c3" xlink:to="loc_us-gaap_OtherAssetsCurrent_c93321d4-b75b-48e0-a377-ff7869e210c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CertainBalanceSheetItemsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:href="jazz-20220331.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductions_18636323-6e44-4780-80b8-84a5ed3d233c" xlink:href="jazz-20220331.xsd#jazz_AccruedRebatesAndOtherSalesDeductions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductions_18636323-6e44-4780-80b8-84a5ed3d233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b454eaee-c889-4ee2-8b47-edfebd3c234d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b454eaee-c889-4ee2-8b47-edfebd3c234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedClinicalTrialLiability_e2e2ba0f-2dca-48b6-8ece-322985105e9b" xlink:href="jazz-20220331.xsd#jazz_AccruedClinicalTrialLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_AccruedClinicalTrialLiability_e2e2ba0f-2dca-48b6-8ece-322985105e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_ea59a04e-165b-4fad-b1e4-c9d06a661236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_InterestPayableCurrent_ea59a04e-165b-4fad-b1e4-c9d06a661236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_99f6a111-47c2-400c-98a9-82bec8502eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_99f6a111-47c2-400c-98a9-82bec8502eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SalesReturnReserve_d7507bb0-91ad-42e1-a566-a07cd0212284" xlink:href="jazz-20220331.xsd#jazz_SalesReturnReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_SalesReturnReserve_d7507bb0-91ad-42e1-a566-a07cd0212284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilities_1af5894a-7f6e-4397-8067-a7135ecee324" xlink:href="jazz-20220331.xsd#jazz_AccruedInventoryRelatedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilities_1af5894a-7f6e-4397-8067-a7135ecee324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_c7d7d602-b2ae-4b31-8b37-dcda94e795fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_c7d7d602-b2ae-4b31-8b37-dcda94e795fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LeaseLiabilityCurrent_1aa352f6-c4a9-4810-aad3-b780bbd32b20" xlink:href="jazz-20220331.xsd#jazz_LeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_LeaseLiabilityCurrent_1aa352f6-c4a9-4810-aad3-b780bbd32b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_f0942ad4-0b7c-4aa0-b5a4-6ca482712fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_f0942ad4-0b7c-4aa0-b5a4-6ca482712fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_42f603ee-8ab0-41c3-b07d-5227b2fb6e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_42f603ee-8ab0-41c3-b07d-5227b2fb6e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedConstructionInProgress_b055bf7d-62cd-476f-97af-06a2a9180beb" xlink:href="jazz-20220331.xsd#jazz_AccruedConstructionInProgress"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_AccruedConstructionInProgress_b055bf7d-62cd-476f-97af-06a2a9180beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedMilestones_9e11d433-d93e-47f1-b474-8fcab070dcb5" xlink:href="jazz-20220331.xsd#jazz_AccruedMilestones"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_jazz_AccruedMilestones_9e11d433-d93e-47f1-b474-8fcab070dcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bd477714-6a51-4d23-937d-4d4a6d0bf69d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_bd477714-6a51-4d23-937d-4d4a6d0bf69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_39f4f252-a881-4421-94d8-6375749adfbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_77e7acb5-ed2c-407f-8120-5b77948ee9fc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_39f4f252-a881-4421-94d8-6375749adfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Debt" xlink:type="simple" xlink:href="jazz-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b0a4ae59-c955-46d6-a8b8-94e77461a785" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_b5799f1d-589b-4c5a-965d-9cff1a57a9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b0a4ae59-c955-46d6-a8b8-94e77461a785" xlink:to="loc_us-gaap_LongTermDebtTextBlock_b5799f1d-589b-4c5a-965d-9cff1a57a9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c92e4343-06af-404c-8e21-d2b6c83b9159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8c7375bf-b49f-4b0c-8ad5-9aeebbb00850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c92e4343-06af-404c-8e21-d2b6c83b9159" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_8c7375bf-b49f-4b0c-8ad5-9aeebbb00850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_f10c5fcc-79ba-4330-895c-353886b997b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c92e4343-06af-404c-8e21-d2b6c83b9159" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_f10c5fcc-79ba-4330-895c-353886b997b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6cca8932-1051-434d-9c39-401aefd695b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6cca8932-1051-434d-9c39-401aefd695b1" xlink:to="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_be07f599-6890-4bef-8202-cc128ca6a957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_be07f599-6890-4bef-8202-cc128ca6a957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4256131f-ea3b-4979-b7c2-d71cbfb85590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_be07f599-6890-4bef-8202-cc128ca6a957" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4256131f-ea3b-4979-b7c2-d71cbfb85590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_39f25cff-772b-4192-ab3b-74f18ecd671e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4256131f-ea3b-4979-b7c2-d71cbfb85590" xlink:to="loc_us-gaap_ConvertibleDebtMember_39f25cff-772b-4192-ab3b-74f18ecd671e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TermLoanMember_f84995f9-9131-4053-9d9d-4ec362628098" xlink:href="jazz-20220331.xsd#jazz_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4256131f-ea3b-4979-b7c2-d71cbfb85590" xlink:to="loc_jazz_TermLoanMember_f84995f9-9131-4053-9d9d-4ec362628098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_272d99d5-4341-4a86-bd51-da175764c747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4256131f-ea3b-4979-b7c2-d71cbfb85590" xlink:to="loc_us-gaap_LineOfCreditMember_272d99d5-4341-4a86-bd51-da175764c747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8949ea00-359e-406f-b6e8-7fd3738773bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:to="loc_us-gaap_DebtInstrumentAxis_8949ea00-359e-406f-b6e8-7fd3738773bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8949ea00-359e-406f-b6e8-7fd3738773bb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_30b28970-6125-4c9b-92fa-e6fb4267eb86" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_30b28970-6125-4c9b-92fa-e6fb4267eb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_46bc6c09-1414-4932-8fcb-b0c9f2312ff1" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_46bc6c09-1414-4932-8fcb-b0c9f2312ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_89634703-e829-4499-be46-3aa193f6bc67" xlink:href="jazz-20220331.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_SeniorNotesDue2029Member_89634703-e829-4499-be46-3aa193f6bc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_ece836a9-3905-4378-ada9-93f886f90602" xlink:href="jazz-20220331.xsd#jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_ece836a9-3905-4378-ada9-93f886f90602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_d824a6e3-e927-4876-a454-2f666e0c7c5c" xlink:href="jazz-20220331.xsd#jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_d824a6e3-e927-4876-a454-2f666e0c7c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_7236c653-b9a7-4d37-adff-baeb3ab20b8d" xlink:href="jazz-20220331.xsd#jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_08220a80-f165-47be-9e67-c2b9287613d7" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_7236c653-b9a7-4d37-adff-baeb3ab20b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_e40b7419-b297-4c85-9b29-47201c22f99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:to="loc_us-gaap_CreditFacilityAxis_e40b7419-b297-4c85-9b29-47201c22f99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8a2029b4-d9d8-48e5-9fd6-25275996443a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_e40b7419-b297-4c85-9b29-47201c22f99a" xlink:to="loc_us-gaap_CreditFacilityDomain_8a2029b4-d9d8-48e5-9fd6-25275996443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9c87e94b-fdd5-42a0-8d9b-5ebc39ee45ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_8a2029b4-d9d8-48e5-9fd6-25275996443a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9c87e94b-fdd5-42a0-8d9b-5ebc39ee45ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ca728b83-aaaf-4d80-92fa-9884c790a3c7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ff1f3550-ef91-4f38-8a42-cb4a335ea3f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ff1f3550-ef91-4f38-8a42-cb4a335ea3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_e8b4f2c1-e362-4212-a880-e80121102019" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_e8b4f2c1-e362-4212-a880-e80121102019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b418693f-1935-41de-9ad5-b4387b7e5f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b418693f-1935-41de-9ad5-b4387b7e5f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a95e3356-0fc6-487a-a221-818521a65fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_LongTermDebt_a95e3356-0fc6-487a-a221-818521a65fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a67b1c7d-94f6-41d2-82b7-90c1eccc0a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_LongTermDebtCurrent_a67b1c7d-94f6-41d2-82b7-90c1eccc0a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_59b8be6d-c004-49c2-af6c-e58c88e25c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_59b8be6d-c004-49c2-af6c-e58c88e25c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c4ad15dc-c3f3-4a78-8e73-873d27a44fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_DebtInstrumentTerm_c4ad15dc-c3f3-4a78-8e73-873d27a44fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_0a41c28f-56d3-4a96-b626-f2f8b713c936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_0a41c28f-56d3-4a96-b626-f2f8b713c936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ded9ee5-a3ef-4d15-9a2f-c4b9ba162806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3ded9ee5-a3ef-4d15-9a2f-c4b9ba162806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_8b206795-c09d-49bb-b16a-f69bb18f605a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0f66dbc9-77b0-47ab-a7ec-adbecfe33298" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_8b206795-c09d-49bb-b16a-f69bb18f605a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtScheduleofLongtermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2026NarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtExchangeableSeniorNotesDue2026NarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2026NarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_650b7cf4-6990-4c80-b4e2-0bff2038bd68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_08cd2bcb-23ec-4b21-b0fc-295fa21c6f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_650b7cf4-6990-4c80-b4e2-0bff2038bd68" xlink:to="loc_us-gaap_DebtInstrumentTable_08cd2bcb-23ec-4b21-b0fc-295fa21c6f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c84bfa6d-e24e-49a8-baa6-d937dcc36190" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08cd2bcb-23ec-4b21-b0fc-295fa21c6f11" xlink:to="loc_us-gaap_DebtInstrumentAxis_c84bfa6d-e24e-49a8-baa6-d937dcc36190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e60b9455-122e-4bcb-825e-4212ad112fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c84bfa6d-e24e-49a8-baa6-d937dcc36190" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e60b9455-122e-4bcb-825e-4212ad112fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_842ff232-e6af-4204-972e-bff6be0b5774" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e60b9455-122e-4bcb-825e-4212ad112fe1" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_842ff232-e6af-4204-972e-bff6be0b5774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2ea37ae7-4856-4de9-bf38-3b95169543ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08cd2bcb-23ec-4b21-b0fc-295fa21c6f11" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2ea37ae7-4856-4de9-bf38-3b95169543ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1816638-e09d-45b2-82a6-917ee1df1dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2ea37ae7-4856-4de9-bf38-3b95169543ee" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1816638-e09d-45b2-82a6-917ee1df1dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_085e8609-2269-4fbc-aef5-68f04a1976ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d1816638-e09d-45b2-82a6-917ee1df1dd7" xlink:to="loc_us-gaap_ConvertibleDebtMember_085e8609-2269-4fbc-aef5-68f04a1976ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_08cd2bcb-23ec-4b21-b0fc-295fa21c6f11" xlink:to="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_92a7a350-e182-4a6a-83c1-833eb233ccf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_92a7a350-e182-4a6a-83c1-833eb233ccf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_87d49096-8a41-4cfa-a2c5-cbb18b32f5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_87d49096-8a41-4cfa-a2c5-cbb18b32f5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aca4f8f3-4d66-4589-aa2b-8e200500a2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_aca4f8f3-4d66-4589-aa2b-8e200500a2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2f32b8bf-92af-4ff1-bc5a-56842da3528a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_2f32b8bf-92af-4ff1-bc5a-56842da3528a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_7877b70e-e740-4591-9c16-761c809e2670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_7877b70e-e740-4591-9c16-761c809e2670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6ca40459-2446-4a6d-9cbf-cadb42e72d88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_6ca40459-2446-4a6d-9cbf-cadb42e72d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_7e64e2f8-0e79-4bbf-9b65-07aaee1846ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_7e64e2f8-0e79-4bbf-9b65-07aaee1846ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_63cc4f9c-7559-49d8-822b-ed2b87771c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_63cc4f9c-7559-49d8-822b-ed2b87771c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ce4b05b6-ab6d-476c-ad92-3806cd8e1f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_ce4b05b6-ab6d-476c-ad92-3806cd8e1f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d8abe89e-3883-4649-a468-6e23665c3cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_InterestExpenseDebt_d8abe89e-3883-4649-a468-6e23665c3cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InterestExpenseDebtContractualCouponRate_10e06f82-d412-4d90-a403-dff43421c8ca" xlink:href="jazz-20220331.xsd#jazz_InterestExpenseDebtContractualCouponRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_jazz_InterestExpenseDebtContractualCouponRate_10e06f82-d412-4d90-a403-dff43421c8ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_5c7bf13b-7a61-4512-aacf-9d96b5e9491b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_566df812-58c9-4782-9a52-582554aa5d5a" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_5c7bf13b-7a61-4512-aacf-9d96b5e9491b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2024NarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtExchangeableSeniorNotesDue2024NarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtExchangeableSeniorNotesDue2024NarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4c213dc1-fa0d-404b-bf17-555c6a0fd2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c213dc1-fa0d-404b-bf17-555c6a0fd2f2" xlink:to="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_40695ecf-f819-4f4d-88ec-007858ca0748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:to="loc_us-gaap_DebtInstrumentAxis_40695ecf-f819-4f4d-88ec-007858ca0748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfd85d3e-f580-40fd-bd8d-071a614f18d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_40695ecf-f819-4f4d-88ec-007858ca0748" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfd85d3e-f580-40fd-bd8d-071a614f18d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_09820ec9-58a7-48da-9e55-6cff95fd9507" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfd85d3e-f580-40fd-bd8d-071a614f18d3" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_09820ec9-58a7-48da-9e55-6cff95fd9507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_4e30bd53-0f20-414c-86fa-f16b29b02741" xlink:href="jazz-20220331.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dfd85d3e-f580-40fd-bd8d-071a614f18d3" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_4e30bd53-0f20-414c-86fa-f16b29b02741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2352176e-a3d7-4a60-bde7-8feae1f1229f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2352176e-a3d7-4a60-bde7-8feae1f1229f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_18a80d64-a8fa-4b04-a54e-b2ca3f40be82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2352176e-a3d7-4a60-bde7-8feae1f1229f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_18a80d64-a8fa-4b04-a54e-b2ca3f40be82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_8453b96d-cafc-4cee-bd2e-8aba6750bcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_18a80d64-a8fa-4b04-a54e-b2ca3f40be82" xlink:to="loc_us-gaap_ConvertibleDebtMember_8453b96d-cafc-4cee-bd2e-8aba6750bcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ab71ad48-013a-456e-96a4-6df9bc2bfd61" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:to="loc_srt_OwnershipAxis_ab71ad48-013a-456e-96a4-6df9bc2bfd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_81c77df9-44d9-45be-89da-b0c05ea9189f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ab71ad48-013a-456e-96a4-6df9bc2bfd61" xlink:to="loc_srt_OwnershipDomain_81c77df9-44d9-45be-89da-b0c05ea9189f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzInvestmentsILimitedMember_a404630d-d6b3-43a6-8a50-39eb0ae1c29b" xlink:href="jazz-20220331.xsd#jazz_JazzInvestmentsILimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_81c77df9-44d9-45be-89da-b0c05ea9189f" xlink:to="loc_jazz_JazzInvestmentsILimitedMember_a404630d-d6b3-43a6-8a50-39eb0ae1c29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_3bd825f2-c539-4a93-a27c-d84c23bd735e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b93d538b-219d-4b22-9811-7b65bc876fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b93d538b-219d-4b22-9811-7b65bc876fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2150b84f-24d6-49fb-b9c8-0138619b22fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2150b84f-24d6-49fb-b9c8-0138619b22fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_ef18bec9-712f-4673-bfbd-85669f2baa5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_ef18bec9-712f-4673-bfbd-85669f2baa5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ebe8c7e7-d75b-45e5-b408-e38cc4707e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ebe8c7e7-d75b-45e5-b408-e38cc4707e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e3ac7a32-c634-4479-b470-4797ab76f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e3ac7a32-c634-4479-b470-4797ab76f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_a6da8d47-7574-4320-9e9c-ed019f8bfeb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_a6da8d47-7574-4320-9e9c-ed019f8bfeb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a97aac5d-a350-48df-9228-83e33cfb6f90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_a97aac5d-a350-48df-9228-83e33cfb6f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_0e9788ad-2a4c-4101-9dfb-1d31037f5cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_0e9788ad-2a4c-4101-9dfb-1d31037f5cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_706b4580-74c7-4d9c-a7aa-15c5dd2ea93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_706b4580-74c7-4d9c-a7aa-15c5dd2ea93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_d93e62ce-2ee3-4a2a-824e-6df6fd8428db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_InterestExpenseDebt_d93e62ce-2ee3-4a2a-824e-6df6fd8428db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InterestExpenseDebtContractualCouponRate_8ca08358-4cee-4822-9e9d-91218178131f" xlink:href="jazz-20220331.xsd#jazz_InterestExpenseDebtContractualCouponRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_jazz_InterestExpenseDebtContractualCouponRate_8ca08358-4cee-4822-9e9d-91218178131f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_860232d8-28e0-44ad-ab16-8468f38fdf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_860232d8-28e0-44ad-ab16-8468f38fdf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_3bd173f2-45d0-4883-aef6-cca375d8bad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a09b6b72-de3d-4094-8c61-8d22f70cbff4" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_3bd173f2-45d0-4883-aef6-cca375d8bad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#DebtScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6a9a1b00-2fea-48d2-81c7-5aac56a68a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6a9a1b00-2fea-48d2-81c7-5aac56a68a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_63dfeeac-fdcf-4e96-b02c-bccb22b871c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_63dfeeac-fdcf-4e96-b02c-bccb22b871c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4f7931e8-4a30-47bb-8488-f011e6f593e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4f7931e8-4a30-47bb-8488-f011e6f593e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_adad95d2-4651-4204-ab40-eab9ed032741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_adad95d2-4651-4204-ab40-eab9ed032741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_bc0c66bd-3d22-409d-81f9-77b7ee39ecdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_bc0c66bd-3d22-409d-81f9-77b7ee39ecdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LongTermDebtMaturityAfterYearFour_80cb07f6-cdf1-4f55-814e-c77d6678439b" xlink:href="jazz-20220331.xsd#jazz_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_jazz_LongTermDebtMaturityAfterYearFour_80cb07f6-cdf1-4f55-814e-c77d6678439b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_3a166c4a-94d3-4061-9c87-e45b130db60a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bbac0d70-175b-459b-9630-cd35a150a22b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_3a166c4a-94d3-4061-9c87-e45b130db60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="jazz-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_16f28973-8732-410c-bc43-49e1e4de88fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_28ca68a1-bd7d-4a1c-aae8-6a606639b345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_16f28973-8732-410c-bc43-49e1e4de88fc" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_28ca68a1-bd7d-4a1c-aae8-6a606639b345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_be8c4fe1-6bb2-4f9b-a2f0-c6bd53bf33bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_23ca08a3-67db-47b3-a6e9-064b423f8296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_be8c4fe1-6bb2-4f9b-a2f0-c6bd53bf33bd" xlink:to="loc_us-gaap_LossContingenciesTable_23ca08a3-67db-47b3-a6e9-064b423f8296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5d7c80c7-7a55-4686-90e6-1a8c053fd55b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_23ca08a3-67db-47b3-a6e9-064b423f8296" xlink:to="loc_srt_LitigationCaseAxis_5d7c80c7-7a55-4686-90e6-1a8c053fd55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5d7c80c7-7a55-4686-90e6-1a8c053fd55b" xlink:to="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TeamstersAndGEHALawsuitsMember_4a0dc31c-6c84-47ca-af91-f85b783dad63" xlink:href="jazz-20220331.xsd#jazz_TeamstersAndGEHALawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:to="loc_jazz_TeamstersAndGEHALawsuitsMember_4a0dc31c-6c84-47ca-af91-f85b783dad63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FarrellLawsuitAndLevyLawsuitMember_3ca8ab20-f628-45eb-89a3-513de32af777" xlink:href="jazz-20220331.xsd#jazz_FarrellLawsuitAndLevyLawsuitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:to="loc_jazz_FarrellLawsuitAndLevyLawsuitMember_3ca8ab20-f628-45eb-89a3-513de32af777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWLitigationMember_61c49b0e-0416-48bd-b534-86b18a08fafb" xlink:href="jazz-20220331.xsd#jazz_GWLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:to="loc_jazz_GWLitigationMember_61c49b0e-0416-48bd-b534-86b18a08fafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AvadelPharmaceuticalsPlcLawsuitMember_a970f5df-14ff-4a06-8d2a-6b43119ccad8" xlink:href="jazz-20220331.xsd#jazz_AvadelPharmaceuticalsPlcLawsuitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:to="loc_jazz_AvadelPharmaceuticalsPlcLawsuitMember_a970f5df-14ff-4a06-8d2a-6b43119ccad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LupinLawsuitMember_9e59b021-c80b-47ac-bc64-1633b25e4bee" xlink:href="jazz-20220331.xsd#jazz_LupinLawsuitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_cee810d8-c45b-4ec4-b97a-643312ff630d" xlink:to="loc_jazz_LupinLawsuitMember_9e59b021-c80b-47ac-bc64-1633b25e4bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_27421ea9-899b-4c4e-a493-fce64f7d1e03" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_23ca08a3-67db-47b3-a6e9-064b423f8296" xlink:to="loc_srt_ProductOrServiceAxis_27421ea9-899b-4c4e-a493-fce64f7d1e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d27953b4-d00c-4a62-b841-710787ff96c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_27421ea9-899b-4c4e-a493-fce64f7d1e03" xlink:to="loc_srt_ProductsAndServicesDomain_d27953b4-d00c-4a62-b841-710787ff96c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XywavMember_0271c81b-583c-486c-adac-fa167bf942bb" xlink:href="jazz-20220331.xsd#jazz_XywavMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d27953b4-d00c-4a62-b841-710787ff96c6" xlink:to="loc_jazz_XywavMember_0271c81b-583c-486c-adac-fa167bf942bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_23ca08a3-67db-47b3-a6e9-064b423f8296" xlink:to="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_158cb389-a742-46d5-bf78-9c88c4de0c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_158cb389-a742-46d5-bf78-9c88c4de0c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c7e82b12-7f5e-40d3-864b-5c172e38bd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_c7e82b12-7f5e-40d3-864b-5c172e38bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InfringedPatentsSuitNumberOfPatents_5200b6f0-e0a2-4535-a154-4cba5a0e7259" xlink:href="jazz-20220331.xsd#jazz_InfringedPatentsSuitNumberOfPatents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:to="loc_jazz_InfringedPatentsSuitNumberOfPatents_5200b6f0-e0a2-4535-a154-4cba5a0e7259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FDAStayOfApprovalPeriod_ab4ce9a0-0b78-48e1-990e-4dc31f1faff9" xlink:href="jazz-20220331.xsd#jazz_FDAStayOfApprovalPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:to="loc_jazz_FDAStayOfApprovalPeriod_ab4ce9a0-0b78-48e1-990e-4dc31f1faff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FDARecognitionOfOrphanDrugExclusivityPeriod_0a80c379-36fc-4252-b924-49ae2e6c35f6" xlink:href="jazz-20220331.xsd#jazz_FDARecognitionOfOrphanDrugExclusivityPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_927e6e25-0e97-4dcf-bf38-c88e2ed90637" xlink:to="loc_jazz_FDARecognitionOfOrphanDrugExclusivityPeriod_0a80c379-36fc-4252-b924-49ae2e6c35f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_6506d215-4173-4e65-9823-efc7d3b0c99d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fc2c3d21-a027-4039-92d2-9590ef28ca19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_6506d215-4173-4e65-9823-efc7d3b0c99d" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_fc2c3d21-a027-4039-92d2-9590ef28ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7d065c15-2acd-479a-9050-ab2962ae1794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ad6d26eb-0d76-4b13-add1-ff63b4e50119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7d065c15-2acd-479a-9050-ab2962ae1794" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ad6d26eb-0d76-4b13-add1-ff63b4e50119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_58bb44fa-764a-4bfe-822f-e7f0e009244e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70df51a0-c623-4848-a809-0710b5adf9e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_58bb44fa-764a-4bfe-822f-e7f0e009244e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70df51a0-c623-4848-a809-0710b5adf9e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d533b9fb-1158-4952-83e8-de6f389229db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70df51a0-c623-4848-a809-0710b5adf9e7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d533b9fb-1158-4952-83e8-de6f389229db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_cf35a5bf-fc23-4c75-bb05-7043d4773d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d533b9fb-1158-4952-83e8-de6f389229db" xlink:to="loc_us-gaap_EquityComponentDomain_cf35a5bf-fc23-4c75-bb05-7043d4773d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_d993436c-0133-429d-89c2-d71ac91e529b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf35a5bf-fc23-4c75-bb05-7043d4773d3f" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_d993436c-0133-429d-89c2-d71ac91e529b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3ef5f439-3a21-4ad1-9076-2bf2d1ae6ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf35a5bf-fc23-4c75-bb05-7043d4773d3f" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_3ef5f439-3a21-4ad1-9076-2bf2d1ae6ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25b17718-0ddd-4ecd-b3a0-ae04d529bcc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_cf35a5bf-fc23-4c75-bb05-7043d4773d3f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_25b17718-0ddd-4ecd-b3a0-ae04d529bcc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ad876870-4a51-4700-92f9-078fa082c497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_70df51a0-c623-4848-a809-0710b5adf9e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ad876870-4a51-4700-92f9-078fa082c497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_ad876870-4a51-4700-92f9-078fa082c497" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_29044e5b-baf6-48a3-bda5-c5ae7ddb5798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:to="loc_us-gaap_StockholdersEquity_29044e5b-baf6-48a3-bda5-c5ae7ddb5798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_7359ea10-a1e6-406b-8d60-e81bd8249f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_7359ea10-a1e6-406b-8d60-e81bd8249f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d2acd56c-6685-4b92-9cc8-e13a65535cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_d2acd56c-6685-4b92-9cc8-e13a65535cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_69ee4725-4a80-4e20-aa28-3c3c22965e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_69ee4725-4a80-4e20-aa28-3c3c22965e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1b096852-e3e4-4f33-acc4-ce4d984979a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2d3054d8-decc-4b38-99e0-c723890c2726" xlink:to="loc_us-gaap_StockholdersEquity_1b096852-e3e4-4f33-acc4-ce4d984979a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="simple" xlink:href="jazz-20220331.xsd#NetIncomeperOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7e6ad8f3-4b2e-464a-a94e-3f23502c01c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_cde4d806-ccd4-47c5-8d72-5888a5337d80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7e6ad8f3-4b2e-464a-a94e-3f23502c01c5" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_cde4d806-ccd4-47c5-8d72-5888a5337d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#NetIncomeLossperOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c8107926-4e78-4fb4-be87-950ea2f09e83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5efaf571-6a19-4a40-848d-54a4a194d548" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c8107926-4e78-4fb4-be87-950ea2f09e83" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5efaf571-6a19-4a40-848d-54a4a194d548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0078cca6-7582-470d-b7ec-6e2379b9763c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c8107926-4e78-4fb4-be87-950ea2f09e83" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_0078cca6-7582-470d-b7ec-6e2379b9763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_df141a2d-81c9-4ce0-80a5-b9f2bad4b345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NumeratorAbstract_b5ddbc54-619b-46a1-b380-632bf439d08e" xlink:href="jazz-20220331.xsd#jazz_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df141a2d-81c9-4ce0-80a5-b9f2bad4b345" xlink:to="loc_jazz_NumeratorAbstract_b5ddbc54-619b-46a1-b380-632bf439d08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b2a95047-75cd-4097-b80e-d0ce52ed42d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NumeratorAbstract_b5ddbc54-619b-46a1-b380-632bf439d08e" xlink:to="loc_us-gaap_NetIncomeLoss_b2a95047-75cd-4097-b80e-d0ce52ed42d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:href="jazz-20220331.xsd#jazz_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df141a2d-81c9-4ce0-80a5-b9f2bad4b345" xlink:to="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a42fbc3d-3aa4-4756-8540-9b8fefcbf319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a42fbc3d-3aa4-4756-8540-9b8fefcbf319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e0eb2e7e-2448-4978-b53d-b7dec6c3878e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e0eb2e7e-2448-4978-b53d-b7dec6c3878e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_058bb9d8-8569-4f67-891f-6be67d92d5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_058bb9d8-8569-4f67-891f-6be67d92d5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa6b96f6-e0d3-4fc2-ad01-6c004cc72193" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_c3c75d47-36a8-43c5-96f1-e9fee7ac2552" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fa6b96f6-e0d3-4fc2-ad01-6c004cc72193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_e58c217b-4784-45f6-9c1a-2ed031577622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_df141a2d-81c9-4ce0-80a5-b9f2bad4b345" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_e58c217b-4784-45f6-9c1a-2ed031577622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2d4bf612-4800-4c95-975d-d9556a5583f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_e58c217b-4784-45f6-9c1a-2ed031577622" xlink:to="loc_us-gaap_EarningsPerShareBasic_2d4bf612-4800-4c95-975d-d9556a5583f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_da4e0c12-6e18-47b7-b8a9-1f61fd5874a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_e58c217b-4784-45f6-9c1a-2ed031577622" xlink:to="loc_us-gaap_EarningsPerShareDiluted_da4e0c12-6e18-47b7-b8a9-1f61fd5874a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e64b5fa1-a588-4353-86c0-db5f08f8354c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a77af872-f57d-46ed-bd2e-59736ccce1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e64b5fa1-a588-4353-86c0-db5f08f8354c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a77af872-f57d-46ed-bd2e-59736ccce1fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65f90734-a0f7-4da3-aac8-e7a013e3ff1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a77af872-f57d-46ed-bd2e-59736ccce1fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65f90734-a0f7-4da3-aac8-e7a013e3ff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ebd90652-25b9-456c-afda-50f1fa5f9adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_65f90734-a0f7-4da3-aac8-e7a013e3ff1d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ebd90652-25b9-456c-afda-50f1fa5f9adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_5f0ab66b-8470-4059-9aa9-f2575c8e9034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ebd90652-25b9-456c-afda-50f1fa5f9adf" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_5f0ab66b-8470-4059-9aa9-f2575c8e9034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_0cadbe29-cf8c-4156-94ce-36fe637258b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ebd90652-25b9-456c-afda-50f1fa5f9adf" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_0cadbe29-cf8c-4156-94ce-36fe637258b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ba22e561-d87d-408e-a804-0685b50ccf95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a77af872-f57d-46ed-bd2e-59736ccce1fe" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ba22e561-d87d-408e-a804-0685b50ccf95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c698e876-2a37-4970-9f8a-071571d70e75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ba22e561-d87d-408e-a804-0685b50ccf95" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c698e876-2a37-4970-9f8a-071571d70e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Revenues" xlink:type="simple" xlink:href="jazz-20220331.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e4a9ff0-c067-46e8-a351-4c3b2e7a5b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ee7ef645-fdee-4897-8ae1-ccbc7969f8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5e4a9ff0-c067-46e8-a351-4c3b2e7a5b75" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ee7ef645-fdee-4897-8ae1-ccbc7969f8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_686f4fb0-ea52-4c9d-aa87-00c9d0ccb74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f94ed195-944c-41e0-a51d-b9b5207d8e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_686f4fb0-ea52-4c9d-aa87-00c9d0ccb74a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_f94ed195-944c-41e0-a51d-b9b5207d8e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_60282c05-3ef9-4c5f-961b-60bc41fd1c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_686f4fb0-ea52-4c9d-aa87-00c9d0ccb74a" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_60282c05-3ef9-4c5f-961b-60bc41fd1c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_552fee46-5b28-4f76-a2e8-ce4a763fff6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_686f4fb0-ea52-4c9d-aa87-00c9d0ccb74a" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_552fee46-5b28-4f76-a2e8-ce4a763fff6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#RevenuesSummaryofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad8a3cb4-b2e9-44ab-8106-1ae67f76176f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bf077732-8958-4915-a3a8-e61222971641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ad8a3cb4-b2e9-44ab-8106-1ae67f76176f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bf077732-8958-4915-a3a8-e61222971641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_82f95860-5352-469f-ad2c-596ceb7f817e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf077732-8958-4915-a3a8-e61222971641" xlink:to="loc_srt_ProductOrServiceAxis_82f95860-5352-469f-ad2c-596ceb7f817e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c576a07f-6298-4e86-a8e0-c1740bed533c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_82f95860-5352-469f-ad2c-596ceb7f817e" xlink:to="loc_srt_ProductsAndServicesDomain_c576a07f-6298-4e86-a8e0-c1740bed533c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_1fc75d53-eed0-4793-b17a-b721c951fe93" xlink:href="jazz-20220331.xsd#jazz_ProductAndServicesProductSalesNetOfDeductionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c576a07f-6298-4e86-a8e0-c1740bed533c" xlink:to="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_1fc75d53-eed0-4793-b17a-b721c951fe93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:href="jazz-20220331.xsd#jazz_OncologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_1fc75d53-eed0-4793-b17a-b721c951fe93" xlink:to="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TotalOxybateMember_5b75bbf9-9b60-4f5e-8ea5-23e231c8fced" xlink:href="jazz-20220331.xsd#jazz_TotalOxybateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_TotalOxybateMember_5b75bbf9-9b60-4f5e-8ea5-23e231c8fced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XyremMember_2359a43e-228a-48e7-9890-be5f0ec7cf8d" xlink:href="jazz-20220331.xsd#jazz_XyremMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_TotalOxybateMember_5b75bbf9-9b60-4f5e-8ea5-23e231c8fced" xlink:to="loc_jazz_XyremMember_2359a43e-228a-48e7-9890-be5f0ec7cf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XywavMember_7739a715-4d53-4e02-9b8a-8798197643b6" xlink:href="jazz-20220331.xsd#jazz_XywavMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_TotalOxybateMember_5b75bbf9-9b60-4f5e-8ea5-23e231c8fced" xlink:to="loc_jazz_XywavMember_7739a715-4d53-4e02-9b8a-8798197643b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NeuroscienceMember_6f0d2c4a-fc9d-4d42-b43e-1e1bb56df02c" xlink:href="jazz-20220331.xsd#jazz_NeuroscienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_NeuroscienceMember_6f0d2c4a-fc9d-4d42-b43e-1e1bb56df02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EpidiolexEpidyolexMember_08a59f35-d1c2-45ee-8461-3efeb7b4b74a" xlink:href="jazz-20220331.xsd#jazz_EpidiolexEpidyolexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_6f0d2c4a-fc9d-4d42-b43e-1e1bb56df02c" xlink:to="loc_jazz_EpidiolexEpidyolexMember_08a59f35-d1c2-45ee-8461-3efeb7b4b74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SunosiMember_84560e44-210a-49ff-a9b0-501c42ae3073" xlink:href="jazz-20220331.xsd#jazz_SunosiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_6f0d2c4a-fc9d-4d42-b43e-1e1bb56df02c" xlink:to="loc_jazz_SunosiMember_84560e44-210a-49ff-a9b0-501c42ae3073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SativexMember_5af57b54-b463-485c-a40d-0fc178b2dfe7" xlink:href="jazz-20220331.xsd#jazz_SativexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_6f0d2c4a-fc9d-4d42-b43e-1e1bb56df02c" xlink:to="loc_jazz_SativexMember_5af57b54-b463-485c-a40d-0fc178b2dfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ZepzelcaMember_fe7640c5-a41a-4a03-bf23-32ce00be92c0" xlink:href="jazz-20220331.xsd#jazz_ZepzelcaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_ZepzelcaMember_fe7640c5-a41a-4a03-bf23-32ce00be92c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_RylazeMember_701c8288-c70c-4745-97cd-7b8a52e8bdf5" xlink:href="jazz-20220331.xsd#jazz_RylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_RylazeMember_701c8288-c70c-4745-97cd-7b8a52e8bdf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_VyxeosMember_e8b407c2-cd5b-4bf7-9c43-2a73188d24ee" xlink:href="jazz-20220331.xsd#jazz_VyxeosMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_VyxeosMember_e8b407c2-cd5b-4bf7-9c43-2a73188d24ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DefitelioDefibrotideMember_d24ad83f-b49a-40d0-8801-25888b14089c" xlink:href="jazz-20220331.xsd#jazz_DefitelioDefibrotideMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_DefitelioDefibrotideMember_d24ad83f-b49a-40d0-8801-25888b14089c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ErwinazeAndErwinaseMember_1b72d7d9-b42d-4cfa-ba6f-ba1d2848e27f" xlink:href="jazz-20220331.xsd#jazz_ErwinazeAndErwinaseMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_2a016247-330d-4961-bb02-dcb62c995bd0" xlink:to="loc_jazz_ErwinazeAndErwinaseMember_1b72d7d9-b42d-4cfa-ba6f-ba1d2848e27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherProductsMember_cbae175e-51e3-4818-bc52-30353f81e840" xlink:href="jazz-20220331.xsd#jazz_OtherProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_1fc75d53-eed0-4793-b17a-b721c951fe93" xlink:to="loc_jazz_OtherProductsMember_cbae175e-51e3-4818-bc52-30353f81e840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_df42e4fd-c097-485b-b54b-75da958ae1be" xlink:href="jazz-20220331.xsd#jazz_ProductAndServicesRoyaltiesAndContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c576a07f-6298-4e86-a8e0-c1740bed533c" xlink:to="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_df42e4fd-c097-485b-b54b-75da958ae1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c0b61cee-4410-416b-b9b7-7b7ce8d34181" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf077732-8958-4915-a3a8-e61222971641" xlink:to="loc_srt_StatementGeographicalAxis_c0b61cee-4410-416b-b9b7-7b7ce8d34181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_45f9b668-4152-493e-9a82-8cf0d926b4d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c0b61cee-4410-416b-b9b7-7b7ce8d34181" xlink:to="loc_srt_SegmentGeographicalDomain_45f9b668-4152-493e-9a82-8cf0d926b4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_28d67753-907f-4879-b9a9-45c9927615fd" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45f9b668-4152-493e-9a82-8cf0d926b4d1" xlink:to="loc_country_US_28d67753-907f-4879-b9a9-45c9927615fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_b6aca9e0-8b44-4df1-b145-b7872e69a9d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45f9b668-4152-493e-9a82-8cf0d926b4d1" xlink:to="loc_srt_EuropeMember_b6aca9e0-8b44-4df1-b145-b7872e69a9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherCountriesMember_5bdce9ec-6f86-4537-8c07-66deb42bb732" xlink:href="jazz-20220331.xsd#jazz_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_45f9b668-4152-493e-9a82-8cf0d926b4d1" xlink:to="loc_jazz_OtherCountriesMember_5bdce9ec-6f86-4537-8c07-66deb42bb732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8c9b00f9-24c9-4de4-bebe-bc713b59d370" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bf077732-8958-4915-a3a8-e61222971641" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8c9b00f9-24c9-4de4-bebe-bc713b59d370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33f1780c-1901-4292-a984-84c5774836a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8c9b00f9-24c9-4de4-bebe-bc713b59d370" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33f1780c-1901-4292-a984-84c5774836a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_316277f0-eae5-495e-b9ac-9e72c4e4c74a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_316277f0-eae5-495e-b9ac-9e72c4e4c74a" xlink:to="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_4bf1911e-372c-49a8-92b0-2e0dcf095a55" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:to="loc_srt_MajorCustomersAxis_4bf1911e-372c-49a8-92b0-2e0dcf095a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4faddb8f-30f3-41fc-a80c-ff7f28cb782c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_4bf1911e-372c-49a8-92b0-2e0dcf095a55" xlink:to="loc_srt_NameOfMajorCustomerDomain_4faddb8f-30f3-41fc-a80c-ff7f28cb782c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExpressScriptsMember_7f9a837c-2602-40dd-a16d-6987d02d8445" xlink:href="jazz-20220331.xsd#jazz_ExpressScriptsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4faddb8f-30f3-41fc-a80c-ff7f28cb782c" xlink:to="loc_jazz_ExpressScriptsMember_7f9a837c-2602-40dd-a16d-6987d02d8445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_McKessonCorporationMember_53f94112-017b-42b5-8c2c-c3422f9e2cd8" xlink:href="jazz-20220331.xsd#jazz_McKessonCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4faddb8f-30f3-41fc-a80c-ff7f28cb782c" xlink:to="loc_jazz_McKessonCorporationMember_53f94112-017b-42b5-8c2c-c3422f9e2cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726ee4e4-c00c-4dd3-8d73-adb51170ce36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726ee4e4-c00c-4dd3-8d73-adb51170ce36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3f067332-ecc3-4e65-9ebe-c66e4ed02e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_726ee4e4-c00c-4dd3-8d73-adb51170ce36" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3f067332-ecc3-4e65-9ebe-c66e4ed02e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_3239fd7d-150c-42d6-aa79-1e3ee5edf5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3f067332-ecc3-4e65-9ebe-c66e4ed02e4b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_3239fd7d-150c-42d6-aa79-1e3ee5edf5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_493a6f8a-3d62-4c9b-92f1-7c89178b9860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_493a6f8a-3d62-4c9b-92f1-7c89178b9860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_98c6f73d-c202-40d3-9717-a096cf55a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_493a6f8a-3d62-4c9b-92f1-7c89178b9860" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_98c6f73d-c202-40d3-9717-a096cf55a0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_a9e043f9-0f4b-48f4-9e38-30502018327c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_98c6f73d-c202-40d3-9717-a096cf55a0e0" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_a9e043f9-0f4b-48f4-9e38-30502018327c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6a1c8359-f471-4b85-8449-935d965400c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_2845c697-3dca-4ad7-a1e6-f00d5ad41b1e" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6a1c8359-f471-4b85-8449-935d965400c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2276c19c-eba7-4b1b-a7cb-42bf3916ed88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6a1c8359-f471-4b85-8449-935d965400c0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2276c19c-eba7-4b1b-a7cb-42bf3916ed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#RevenuesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ae316533-d03e-47f7-9ddd-debdca6ad565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SummaryOfDeferredRevenueTable_eb9ee64e-3e1a-4ebc-9a51-cf1ad6ea1ba9" xlink:href="jazz-20220331.xsd#jazz_SummaryOfDeferredRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ae316533-d03e-47f7-9ddd-debdca6ad565" xlink:to="loc_jazz_SummaryOfDeferredRevenueTable_eb9ee64e-3e1a-4ebc-9a51-cf1ad6ea1ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_257c165a-cac5-4500-986e-329fdc49fdf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_eb9ee64e-3e1a-4ebc-9a51-cf1ad6ea1ba9" xlink:to="loc_srt_RangeAxis_257c165a-cac5-4500-986e-329fdc49fdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8db8842f-53f5-4975-9326-b27068c64ba7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_257c165a-cac5-4500-986e-329fdc49fdf6" xlink:to="loc_srt_RangeMember_8db8842f-53f5-4975-9326-b27068c64ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e270ffae-3d48-495a-84f0-fe29ee075bd6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8db8842f-53f5-4975-9326-b27068c64ba7" xlink:to="loc_srt_MinimumMember_e270ffae-3d48-495a-84f0-fe29ee075bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9308c35-e9f1-4848-8038-6577582a16c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8db8842f-53f5-4975-9326-b27068c64ba7" xlink:to="loc_srt_MaximumMember_b9308c35-e9f1-4848-8038-6577582a16c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_39e6bcc2-8aa3-4452-8e16-2871d1abf673" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_eb9ee64e-3e1a-4ebc-9a51-cf1ad6ea1ba9" xlink:to="loc_srt_MajorCustomersAxis_39e6bcc2-8aa3-4452-8e16-2871d1abf673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_4948e0c4-e314-41af-afdf-33f8c8883924" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_39e6bcc2-8aa3-4452-8e16-2871d1abf673" xlink:to="loc_srt_NameOfMajorCustomerDomain_4948e0c4-e314-41af-afdf-33f8c8883924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NipponShinyakuCo.Ltd.Member_2cebbdd2-19e8-4a24-ac57-75744f7d2a85" xlink:href="jazz-20220331.xsd#jazz_NipponShinyakuCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_4948e0c4-e314-41af-afdf-33f8c8883924" xlink:to="loc_jazz_NipponShinyakuCo.Ltd.Member_2cebbdd2-19e8-4a24-ac57-75744f7d2a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:href="jazz-20220331.xsd#jazz_SummaryOfDeferredRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_eb9ee64e-3e1a-4ebc-9a51-cf1ad6ea1ba9" xlink:to="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_RevenuePerformanceObligationPaymentTerms_7516b628-1d85-4fa7-bc33-8a54756ec74e" xlink:href="jazz-20220331.xsd#jazz_RevenuePerformanceObligationPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:to="loc_jazz_RevenuePerformanceObligationPaymentTerms_7516b628-1d85-4fa7-bc33-8a54756ec74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LicensingAgreementNumberOfAgreements_dc85a451-25cb-4a1c-ad08-48451df821ae" xlink:href="jazz-20220331.xsd#jazz_LicensingAgreementNumberOfAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:to="loc_jazz_LicensingAgreementNumberOfAgreements_dc85a451-25cb-4a1c-ad08-48451df821ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9b8503c7-e9c8-48f7-99ea-4788c89911f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_9b8503c7-e9c8-48f7-99ea-4788c89911f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_5e8eb2b8-146e-420f-89f5-d10c98943e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_29cd3ee7-6ebb-4923-ac13-6e6755742d86" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_5e8eb2b8-146e-420f-89f5-d10c98943e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#RevenuesSummaryofContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8fe08779-b40c-4f22-9c46-14b12f13a73c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_841dc7c5-116c-4b21-ae04-8038012b56a8" xlink:href="jazz-20220331.xsd#jazz_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8fe08779-b40c-4f22-9c46-14b12f13a73c" xlink:to="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_841dc7c5-116c-4b21-ae04-8038012b56a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_0e9d8c7a-4169-4396-b86c-70d173bbc1ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_841dc7c5-116c-4b21-ae04-8038012b56a8" xlink:to="loc_us-gaap_ContractWithCustomerLiability_0e9d8c7a-4169-4396-b86c-70d173bbc1ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ca34c50b-f24a-457a-a092-cb2e9b6a45e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_841dc7c5-116c-4b21-ae04-8038012b56a8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ca34c50b-f24a-457a-a092-cb2e9b6a45e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_2c94ae09-7c9d-4e61-b91a-df4c29fa76e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_841dc7c5-116c-4b21-ae04-8038012b56a8" xlink:to="loc_us-gaap_ContractWithCustomerLiability_2c94ae09-7c9d-4e61-b91a-df4c29fa76e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2724d1f-9649-473d-a120-314adc3057a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4ef715c3-dbf0-47c8-9ad7-e37784449db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2724d1f-9649-473d-a120-314adc3057a1" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4ef715c3-dbf0-47c8-9ad7-e37784449db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec7a2762-ffbf-4b97-b897-9680fa50f648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6783934a-b3e4-4268-bef1-4ae030ab4989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec7a2762-ffbf-4b97-b897-9680fa50f648" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6783934a-b3e4-4268-bef1-4ae030ab4989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6446c204-d446-46af-af08-acbe135b2a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec7a2762-ffbf-4b97-b897-9680fa50f648" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_6446c204-d446-46af-af08-acbe135b2a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_5039834f-aec0-41d7-8b64-4c71972c8f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec7a2762-ffbf-4b97-b897-9680fa50f648" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_5039834f-aec0-41d7-8b64-4c71972c8f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b99f19a1-e77a-4993-8b2a-acdd05d69b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5d7382e8-eafa-4d98-aa5e-eda3cb51cc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b99f19a1-e77a-4993-8b2a-acdd05d69b3d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5d7382e8-eafa-4d98-aa5e-eda3cb51cc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_456fc212-f81e-466a-a780-3736d8de6104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5d7382e8-eafa-4d98-aa5e-eda3cb51cc4c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_456fc212-f81e-466a-a780-3736d8de6104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6e83efea-b577-4299-b4b3-f8fc8037263a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_456fc212-f81e-466a-a780-3736d8de6104" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6e83efea-b577-4299-b4b3-f8fc8037263a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5007563a-bb2d-4426-acbe-3297450a68f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6e83efea-b577-4299-b4b3-f8fc8037263a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_5007563a-bb2d-4426-acbe-3297450a68f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e4988bac-3f38-45a3-860b-d47785342c05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6e83efea-b577-4299-b4b3-f8fc8037263a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e4988bac-3f38-45a3-860b-d47785342c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_7fd719ad-27cf-45ce-9804-32965f3a3c88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6e83efea-b577-4299-b4b3-f8fc8037263a" xlink:to="loc_us-gaap_CostOfSalesMember_7fd719ad-27cf-45ce-9804-32965f3a3c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdad4b68-61a1-4fa1-8347-fcdf955f3ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5d7382e8-eafa-4d98-aa5e-eda3cb51cc4c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdad4b68-61a1-4fa1-8347-fcdf955f3ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_1fb6a904-dab6-4111-b643-ce3fa2c28d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdad4b68-61a1-4fa1-8347-fcdf955f3ece" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_1fb6a904-dab6-4111-b643-ce3fa2c28d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d1ccbd83-7e6c-4019-a388-8f3afd63902e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdad4b68-61a1-4fa1-8347-fcdf955f3ece" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_d1ccbd83-7e6c-4019-a388-8f3afd63902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_f2cb062d-93cc-4d08-85b3-31cf1b040f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_bdad4b68-61a1-4fa1-8347-fcdf955f3ece" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_f2cb062d-93cc-4d08-85b3-31cf1b040f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d75414-310f-4e42-9265-71084820fe10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_324d7c0a-1a95-4294-8a99-92a3f497a4b2" xlink:href="jazz-20220331.xsd#jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f5d75414-310f-4e42-9265-71084820fe10" xlink:to="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_324d7c0a-1a95-4294-8a99-92a3f497a4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2c9a4462-da8b-40ff-a717-e7cc96677544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_324d7c0a-1a95-4294-8a99-92a3f497a4b2" xlink:to="loc_us-gaap_AwardTypeAxis_2c9a4462-da8b-40ff-a717-e7cc96677544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d4cbe18-83ce-41a9-aff5-c8f3fc2fb324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2c9a4462-da8b-40ff-a717-e7cc96677544" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d4cbe18-83ce-41a9-aff5-c8f3fc2fb324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9391d286-3f9a-4784-99ae-bf9b850ab0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6d4cbe18-83ce-41a9-aff5-c8f3fc2fb324" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9391d286-3f9a-4784-99ae-bf9b850ab0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:href="jazz-20220331.xsd#jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_324d7c0a-1a95-4294-8a99-92a3f497a4b2" xlink:to="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9ebf4b65-6b49-4072-94f7-b816c6f7654c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9ebf4b65-6b49-4072-94f7-b816c6f7654c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b358d32a-ca86-42da-9681-39887c2103ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b358d32a-ca86-42da-9681-39887c2103ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_18fb96f2-70c4-4687-ada6-f4f2fabb1959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_18fb96f2-70c4-4687-ada6-f4f2fabb1959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46c071c1-c1aa-472f-ba0d-6fb08299a809" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_46c071c1-c1aa-472f-ba0d-6fb08299a809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f684e2e3-b58d-4efa-ba56-2efe1c3e9c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_f684e2e3-b58d-4efa-ba56-2efe1c3e9c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_a69af766-a2c9-41e6-9971-c538471b75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_a69af766-a2c9-41e6-9971-c538471b75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c04bdfe4-807a-48ed-a933-786b7482ab4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_ba0c2a0c-84f0-4513-af4d-d82d71581cc2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c04bdfe4-807a-48ed-a933-786b7482ab4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationRestrictedUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24f8bb0c-7458-4de8-8b4c-b4c3579dc1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f2aa393-d436-4d9e-8b58-a31e050bbfe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24f8bb0c-7458-4de8-8b4c-b4c3579dc1f7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f2aa393-d436-4d9e-8b58-a31e050bbfe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cd29f1a5-f6b5-41d7-b427-687f36950765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f2aa393-d436-4d9e-8b58-a31e050bbfe6" xlink:to="loc_us-gaap_AwardTypeAxis_cd29f1a5-f6b5-41d7-b427-687f36950765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_72636a55-879e-48c4-8513-cfc3995b4675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cd29f1a5-f6b5-41d7-b427-687f36950765" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_72636a55-879e-48c4-8513-cfc3995b4675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9f5455a9-5da2-47b1-b8bc-a620e72c4646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_72636a55-879e-48c4-8513-cfc3995b4675" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9f5455a9-5da2-47b1-b8bc-a620e72c4646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11d41bc5-9945-4488-be72-308b502c5c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f2aa393-d436-4d9e-8b58-a31e050bbfe6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11d41bc5-9945-4488-be72-308b502c5c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2ab80488-e092-4bb1-a3c1-56d5bdebfefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11d41bc5-9945-4488-be72-308b502c5c23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2ab80488-e092-4bb1-a3c1-56d5bdebfefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4ca8fa4e-1209-4684-aa51-17c5945057de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11d41bc5-9945-4488-be72-308b502c5c23" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4ca8fa4e-1209-4684-aa51-17c5945057de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2fd25d9a-91fa-4f36-9e76-d4e9573cc89e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ae967792-f7aa-42b7-be90-c65f1797b192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2fd25d9a-91fa-4f36-9e76-d4e9573cc89e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ae967792-f7aa-42b7-be90-c65f1797b192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bc7c51cf-6d8b-4920-8464-ca8a21f75811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ae967792-f7aa-42b7-be90-c65f1797b192" xlink:to="loc_us-gaap_AwardTypeAxis_bc7c51cf-6d8b-4920-8464-ca8a21f75811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7aaf529f-2ec0-465f-a905-34e80af045a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bc7c51cf-6d8b-4920-8464-ca8a21f75811" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7aaf529f-2ec0-465f-a905-34e80af045a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4776bcb1-4894-4fc0-8439-5e099271745d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7aaf529f-2ec0-465f-a905-34e80af045a8" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4776bcb1-4894-4fc0-8439-5e099271745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_797e0dd1-0eae-4d30-9975-0425a50884e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7aaf529f-2ec0-465f-a905-34e80af045a8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_797e0dd1-0eae-4d30-9975-0425a50884e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_b9f992b8-f172-4fdb-ae44-56a86dd5eaab" xlink:href="jazz-20220331.xsd#jazz_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7aaf529f-2ec0-465f-a905-34e80af045a8" xlink:to="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_b9f992b8-f172-4fdb-ae44-56a86dd5eaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_08ffb39a-ed04-4e47-b445-d4fb4e555852" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ae967792-f7aa-42b7-be90-c65f1797b192" xlink:to="loc_srt_RangeAxis_08ffb39a-ed04-4e47-b445-d4fb4e555852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6ec3d31e-add0-43c3-a3cb-a5a52ef1e7e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_08ffb39a-ed04-4e47-b445-d4fb4e555852" xlink:to="loc_srt_RangeMember_6ec3d31e-add0-43c3-a3cb-a5a52ef1e7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3444f1e2-e68b-4167-8684-33f5bd348e01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6ec3d31e-add0-43c3-a3cb-a5a52ef1e7e1" xlink:to="loc_srt_MinimumMember_3444f1e2-e68b-4167-8684-33f5bd348e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8d7a71f6-7da3-4143-89a3-ec9f106c12b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6ec3d31e-add0-43c3-a3cb-a5a52ef1e7e1" xlink:to="loc_srt_MaximumMember_8d7a71f6-7da3-4143-89a3-ec9f106c12b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ae967792-f7aa-42b7-be90-c65f1797b192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7c03b690-9f07-4c4e-b3a9-b3679e2920bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7c03b690-9f07-4c4e-b3a9-b3679e2920bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02fd2a27-2e69-40ae-bfc7-925344f2e81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_02fd2a27-2e69-40ae-bfc7-925344f2e81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted_3a5afab8-59bd-417c-8b17-440077db7f19" xlink:href="jazz-20220331.xsd#jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted_3a5afab8-59bd-417c-8b17-440077db7f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03e7ea5b-aea5-49d7-bd54-9b002ab151cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03e7ea5b-aea5-49d7-bd54-9b002ab151cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c23a8121-8efb-4ce9-9dd4-515dfd577e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c23a8121-8efb-4ce9-9dd4-515dfd577e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa29a6f3-2d39-4ec0-ab02-d60de4da7072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e0aa47c0-89fe-4583-a481-6fd44fab54d1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa29a6f3-2d39-4ec0-ab02-d60de4da7072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofPerformancebasedRSUsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#ShareBasedCompensationScheduleofPerformancebasedRSUsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofPerformancebasedRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24fa717c-6e79-4724-bc4c-332798bc27fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5005b24d-5349-4cd1-b49a-c472dae2772e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_24fa717c-6e79-4724-bc4c-332798bc27fb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5005b24d-5349-4cd1-b49a-c472dae2772e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1049e10b-d192-4a20-a17a-762e325f4998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5005b24d-5349-4cd1-b49a-c472dae2772e" xlink:to="loc_us-gaap_AwardTypeAxis_1049e10b-d192-4a20-a17a-762e325f4998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be93ad64-ec11-4f74-8781-bb7e15f24ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1049e10b-d192-4a20-a17a-762e325f4998" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be93ad64-ec11-4f74-8781-bb7e15f24ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_5f5319bf-a54b-4460-aa53-08e870253793" xlink:href="jazz-20220331.xsd#jazz_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be93ad64-ec11-4f74-8781-bb7e15f24ba0" xlink:to="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_5f5319bf-a54b-4460-aa53-08e870253793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d81dbde-3e9f-482a-8dd6-32e84c5ba16f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5005b24d-5349-4cd1-b49a-c472dae2772e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d81dbde-3e9f-482a-8dd6-32e84c5ba16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_81c95346-74d1-415f-b8c6-5ec3fb420e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d81dbde-3e9f-482a-8dd6-32e84c5ba16f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_81c95346-74d1-415f-b8c6-5ec3fb420e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cf7d9df8-8cbf-4768-a9a0-55a15b949a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0d81dbde-3e9f-482a-8dd6-32e84c5ba16f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_cf7d9df8-8cbf-4768-a9a0-55a15b949a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jazz-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c0eace1f-bb02-4dad-b3af-18b1b453f9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_65fcd7b0-c02b-455e-98ac-07e9686bd91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c0eace1f-bb02-4dad-b3af-18b1b453f9ff" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_65fcd7b0-c02b-455e-98ac-07e9686bd91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f4f3b869-97c7-4ea1-982d-898d9e8a86dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4a4e4a1-2277-4a95-83e9-834b429161c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f4f3b869-97c7-4ea1-982d-898d9e8a86dd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4a4e4a1-2277-4a95-83e9-834b429161c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetsHeldforSale" xlink:type="simple" xlink:href="jazz-20220331.xsd#AssetsHeldforSale"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/AssetsHeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_df8e8c4c-d414-4a35-9d44-00a78f89d01e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b823abfe-5aea-4423-938d-50c7230d6674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_df8e8c4c-d414-4a35-9d44-00a78f89d01e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_b823abfe-5aea-4423-938d-50c7230d6674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetsHeldforSaleTables" xlink:type="simple" xlink:href="jazz-20220331.xsd#AssetsHeldforSaleTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/AssetsHeldforSaleTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_54798e64-bfa2-4fe2-85a4-2ad1b036db1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d5bfb453-2ce5-4ffa-8219-c025014d5a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_54798e64-bfa2-4fe2-85a4-2ad1b036db1d" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d5bfb453-2ce5-4ffa-8219-c025014d5a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#AssetsHeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/AssetsHeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f6510922-c79d-49fd-af96-46bda48487a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c757500a-6ce9-46df-b2ee-2f1c17d43b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_f6510922-c79d-49fd-af96-46bda48487a7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c757500a-6ce9-46df-b2ee-2f1c17d43b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_9e960a71-eb8b-4e6c-8cb1-3c83f24fe702" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c757500a-6ce9-46df-b2ee-2f1c17d43b4f" xlink:to="loc_srt_StatementScenarioAxis_9e960a71-eb8b-4e6c-8cb1-3c83f24fe702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_b71dc2df-a2a2-470d-9287-9054c7fa81fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_9e960a71-eb8b-4e6c-8cb1-3c83f24fe702" xlink:to="loc_srt_ScenarioUnspecifiedDomain_b71dc2df-a2a2-470d-9287-9054c7fa81fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_63cc5404-03ef-4fdd-a045-76b378dc14f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_b71dc2df-a2a2-470d-9287-9054c7fa81fb" xlink:to="loc_srt_ScenarioForecastMember_63cc5404-03ef-4fdd-a045-76b378dc14f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_443e68f4-a082-4ab4-977d-fe99b64e5bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c757500a-6ce9-46df-b2ee-2f1c17d43b4f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_443e68f4-a082-4ab4-977d-fe99b64e5bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DisposalGroupIncludingDiscontinuedOperationUpfrontPaymentToBeReceived_dd020d46-6bee-4a02-8391-510dff48e014" xlink:href="jazz-20220331.xsd#jazz_DisposalGroupIncludingDiscontinuedOperationUpfrontPaymentToBeReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_443e68f4-a082-4ab4-977d-fe99b64e5bc6" xlink:to="loc_jazz_DisposalGroupIncludingDiscontinuedOperationUpfrontPaymentToBeReceived_dd020d46-6bee-4a02-8391-510dff48e014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DisposalGroupIncludingDiscontinuedOperationNumberOfDaysForExUSTransactionToCloseAfterUSTransactionCloses_5fec4126-e5a1-4cb7-a4fa-ae81b2947c78" xlink:href="jazz-20220331.xsd#jazz_DisposalGroupIncludingDiscontinuedOperationNumberOfDaysForExUSTransactionToCloseAfterUSTransactionCloses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_443e68f4-a082-4ab4-977d-fe99b64e5bc6" xlink:to="loc_jazz_DisposalGroupIncludingDiscontinuedOperationNumberOfDaysForExUSTransactionToCloseAfterUSTransactionCloses_5fec4126-e5a1-4cb7-a4fa-ae81b2947c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_280c1df2-b999-4953-8d5a-efabea372864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_443e68f4-a082-4ab4-977d-fe99b64e5bc6" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_280c1df2-b999-4953-8d5a-efabea372864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/AssetsHeldforSaleConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#AssetsHeldforSaleConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/AssetsHeldforSaleConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ce779376-5f06-4409-8898-e31f7992208b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssets_ce779376-5f06-4409-8898-e31f7992208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a59fe1dd-d4cf-4ca9-b536-4660a57ffa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventory1_a59fe1dd-d4cf-4ca9-b536-4660a57ffa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_405236ff-ee2a-4638-9d62-e5febdff9171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwill1_405236ff-ee2a-4638-9d62-e5febdff9171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d929599f-3a27-4757-b1d2-65c397029393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_d929599f-3a27-4757-b1d2-65c397029393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a765a678-03e3-4392-b492-e0889a06552b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3e35566d-2ba7-410a-9eec-265a0176034f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_a765a678-03e3-4392-b492-e0889a06552b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEvents" xlink:type="simple" xlink:href="jazz-20220331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_511fadb0-6fd1-428b-98f1-67ffb43d6f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_4500ab62-ff86-4835-80da-b03a508b4c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_511fadb0-6fd1-428b-98f1-67ffb43d6f55" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_4500ab62-ff86-4835-80da-b03a508b4c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="jazz-20220331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_362a5787-f317-4bb6-af0c-90ba2f854d02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_362a5787-f317-4bb6-af0c-90ba2f854d02" xlink:to="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_df821c3d-ce2e-419a-908c-c2ba2d7bdb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_df821c3d-ce2e-419a-908c-c2ba2d7bdb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_3732ac05-1022-43cb-9bb6-c00561e003df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_df821c3d-ce2e-419a-908c-c2ba2d7bdb03" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_3732ac05-1022-43cb-9bb6-c00561e003df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_e49a00e1-8725-43b6-b27a-d7154fe103c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_3732ac05-1022-43cb-9bb6-c00561e003df" xlink:to="loc_us-gaap_SubsequentEventMember_e49a00e1-8725-43b6-b27a-d7154fe103c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_87be1f42-eb3b-4480-a312-4328f72b3ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_87be1f42-eb3b-4480-a312-4328f72b3ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_d6f637f6-dc1a-4671-9f9c-651fd9665869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_87be1f42-eb3b-4480-a312-4328f72b3ef8" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_d6f637f6-dc1a-4671-9f9c-651fd9665869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_UpfrontPaymentsMember_0e4fa165-12fe-4144-bec4-5e2a7e5ba634" xlink:href="jazz-20220331.xsd#jazz_UpfrontPaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d6f637f6-dc1a-4671-9f9c-651fd9665869" xlink:to="loc_jazz_UpfrontPaymentsMember_0e4fa165-12fe-4144-bec4-5e2a7e5ba634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_MilestonePaymentMember_eaf9e1ec-14fe-4900-b2dc-55e470d7ca74" xlink:href="jazz-20220331.xsd#jazz_MilestonePaymentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_d6f637f6-dc1a-4671-9f9c-651fd9665869" xlink:to="loc_jazz_MilestonePaymentMember_eaf9e1ec-14fe-4900-b2dc-55e470d7ca74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f339933c-7ca1-42c5-bbfe-5ae7e5e608f9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:to="loc_srt_CounterpartyNameAxis_f339933c-7ca1-42c5-bbfe-5ae7e5e608f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_246c649a-1c52-48ea-9fa9-b4301cdd3564" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f339933c-7ca1-42c5-bbfe-5ae7e5e608f9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_246c649a-1c52-48ea-9fa9-b4301cdd3564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_WerewolfMember_78077ef8-af4a-4073-8f1d-22256e776e46" xlink:href="jazz-20220331.xsd#jazz_WerewolfMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_246c649a-1c52-48ea-9fa9-b4301cdd3564" xlink:to="loc_jazz_WerewolfMember_78077ef8-af4a-4073-8f1d-22256e776e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AcquiredIPRDMember_52c90da7-b7b0-46b8-8139-e98ce3a3ecad" xlink:href="jazz-20220331.xsd#jazz_AcquiredIPRDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_246c649a-1c52-48ea-9fa9-b4301cdd3564" xlink:to="loc_jazz_AcquiredIPRDMember_52c90da7-b7b0-46b8-8139-e98ce3a3ecad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SumitomoMember_911d1087-e399-4df8-844d-2f139f4793ef" xlink:href="jazz-20220331.xsd#jazz_SumitomoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_246c649a-1c52-48ea-9fa9-b4301cdd3564" xlink:to="loc_jazz_SumitomoMember_911d1087-e399-4df8-844d-2f139f4793ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_19e31564-3141-400c-be53-b1d69d54c0b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:to="loc_srt_StatementScenarioAxis_19e31564-3141-400c-be53-b1d69d54c0b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9de5d8c5-47bb-4802-94f7-daf9984ac5ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_19e31564-3141-400c-be53-b1d69d54c0b3" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9de5d8c5-47bb-4802-94f7-daf9984ac5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_71c4adee-6bdf-4a6d-9afe-bae6b59e8d16" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9de5d8c5-47bb-4802-94f7-daf9984ac5ee" xlink:to="loc_srt_ScenarioForecastMember_71c4adee-6bdf-4a6d-9afe-bae6b59e8d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_78720d2c-f98d-4596-8b4b-6a79d174fa5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_eb74bbec-5485-4220-ae11-dba1db79f531" xlink:to="loc_us-gaap_SubsequentEventLineItems_78720d2c-f98d-4596-8b4b-6a79d174fa5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NumberOfPreclinicalCompoundsDevelopmentAndCommercializationRightsAcquired_bb378489-42fe-43e7-9ddf-c4cd100cde09" xlink:href="jazz-20220331.xsd#jazz_NumberOfPreclinicalCompoundsDevelopmentAndCommercializationRightsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_78720d2c-f98d-4596-8b4b-6a79d174fa5b" xlink:to="loc_jazz_NumberOfPreclinicalCompoundsDevelopmentAndCommercializationRightsAcquired_bb378489-42fe-43e7-9ddf-c4cd100cde09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_fdf45660-d22d-4bb3-974d-1ffe2bf5fd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_78720d2c-f98d-4596-8b4b-6a79d174fa5b" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_fdf45660-d22d-4bb3-974d-1ffe2bf5fd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4f5ace62-1f5b-4f21-99e4-e68b5bb16b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_78720d2c-f98d-4596-8b4b-6a79d174fa5b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4f5ace62-1f5b-4f21-99e4-e68b5bb16b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
